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Antiquitin (ATQ) is a member of the aldehyde dehydrogenase (ALDH) 
superfamily. The plant and animal proteins share high degree of amino acid sequence 
homology. Plant ATQ is related to osmoregulation. Recently, it is reported that 
mutations in the ATQ gene is associated with pyridoxine-dependent seizures (PDS), 
in which human ATQ acts as an a -aminoadipic semialdehyde ( a -AASA) 
dehydrogenase to remove the metabolite from lysine catabolism. Following 
extensive work done on seabream ATQ (sbATQ) in out laboratory, this project 
continues to investigate the human enzyme by recombinant techniques and protein 
crystallography. 
The recombinant huATQ protein produced by the E. coli expression system 
demonstrated marked ALDH activity. The protein was a homotetramer with subunit 
molecular weight of 55400. Substrate specificity study revealed that recombinant 
huATQ had an extremely low Km value of 0.026 mM and very high catalytic 
efficiency of 6.4 U/mg towards a -AASA, supporting the involvement of this 
enzyme in the catabolic pathway of lysine. 
Crystal Structure of human ATQ was solved to 2.6 A in complex with NADH. 
The tetrameric structure of huATQ is a dimer of dimer. Each monomer subunit is 
comprised of an NAD+ binding domain, a catalytic domain and an oligomerization 
domain. Similar to other ALDH structures, an atypical Rossmann fold is present for 
cofactor binding. The electron density of NADH in the structure is disordered, and its 
binding is in "hydride transfer" conformation. A pair of oppositely charged residues, 
El21 and R301, are found to guard the substrate entrance channel and responsible for 
V 
substrate specificity. 
A series of PDS-related mutants were created for kinetics study. These data, in line 
with the crystal structure, provide a molecular explanation for the inefficient 
oxidation of a -A AS A in PDS patients carrying mutations in their ATQ gene. 
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Chapter 1 Introduction 
CHAPTER 1 
INTRODUCTION 
1.1 Aldehyde Dehydrogenase Superfamily 
1.1.1 Classification and Substrate Specificities of Aldehyde 
Dehydrogenases 
Aldehyde dehydrogenase (ALDH; EC 1.2.1.3) is a family of enzymes oxidizing 
a wide variety of endogenous and exogenous aldehydes to their corresponding acids 
in the presence of NAD(P)+. Endogenous aldehydes arise from the metabolism of 
amino acids, biogenic amines, vitamins, steroids and lipids; while exogenous aldehydes 
are generated as intermediates or products through the biotransfomation of a large 
number of drugs and environmental agents. The existence of these aldehydes may 
sometimes pose threats on living systems, as they are highly reactive electrophilic 
compounds which interact with thiol and amino groups. Harmful products are often 
produced in these reactions and lead to cytotoxic or even mutagenic effects. Thus the 
presence of an efficient system to selectively remove these aldehydes is essential. The 
ALDH system (Farres et al., 1995) represents the main pathway for detoxification, 
despite other systems such as aldehyde oxidase (Rajagopalan et al., 1962) and 
microsomal aldehyde oxidizing system (Riveros-Rosas et al., 1997) also contribute to 
the process. 
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ALDHs are known to distribute widely in different organisms, as simple as 
prokaryotes like bacteria, also yeast, plants, and more advanced animals like human 
(Vasiliou, 1997). Analysis of the ALDH gene family showed that the human genome 
contains 19 putatively functional genes and 3 pseudogenes (Vasiliou & Nebert, 2005). 
The 19 annotated ALDHs in human are classified into families and subfamilies 
according to the gene nomenclature system established in 1998 (Vasiliou et al, 1999). 
An ALDH protein from one gene family is defined as having <40% amino-acid 
identity to that from another family. Two members of the same subfamily exhibit 
>60% amino-acid identity. Dentrogram of the 19 human ALDH genes is shown in 
Figure 1.1. 
Alignment of 145 full-length ALDH-related sequences revealed only four 
invariant residues (Perozich et al.’ 1999): two glycines (G246 and G298), a 
phenylalanine (F401) involved in NAD+ binding, and a glutamic acid (E399) that 
coordinates the nicotinamide ribose in certain enzyme-NAD+ binary complex crystal 
structures, but which may also serve as a general base for the catalytic reaction (Liu 
et (3/.,1997; Steinmetz et al., 1997). Among all ALDHs with demonstrated 
dehydrogenase activity, the cysteine (C302) providing the catalytic thiol and a 
neighboring asparagine residue (N167) are conserved. Sixteen residues are conserved 
in at least 95% of the sequences, and most of them are found to cluster into sequence 
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Figure 1.1 Dentrogram of the 19 human ALDH genes. 
Alternative splice variants of ALDH genes and the 3 pseudogenes are not included in 
the construction of this tree. The neighbour-joining method gives various branches of 
different lengths, reflecting that evolutionary divergence is not the same between 
different branches of the gene tree (Vasiliou & Nebert, 2005). 
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motifs around the active site of the enzyme. 
ALDHs were found to divide into two main trunks of the phylogenetic tree. The 
larger "Class 3" trunk contains mostly substrate-specific ALDH families, and the 
other "Class 1/2" trunk contains mostly variable substrate ALDH families (Perozich 
et al., 1998). Although most ALDHs like ALDHl and ALDH2 display broad 
substrate specificities, oxidizing a variety of both aliphatic and aromatic aldehydes, 
other forms possess narrower substrate preferences. Examples are betaine 
dehydrogenase (Hjelmqvist et al, 2003) and non-phosphorylating glyceraldehyde 
3-phosphate dehydrogenase (G3PDH) (Gomez Casati et al., 2000). Most ALDHs 
prefer NAD+ as the cofactor for the irreversible oxidation reaction, but ALDH3 can 
utilize both NAD+ and NADP+ efficiently (Perozich et al, 2001). Other strictly 
NADP+-specific ALDH families, non-phosphorylating G3PDH (Gomez Casati et al, 
2000) and 10-formyltetrahydrofolate dehydrogenases (10-FTHFDH) (Cook et al., 1995), 
are also present to show the variation in cofactor usage. 
1.1.2 Multiple Functions of Aldehyde Dehydrogenases and their Roles in 
Metabolism 
The most well-known family of ALDH is probably ALDH2 which actively 
participates in alcohol metabolism (Seitz & Meier, 2007; Crabb et al., 2004). Ethanol 
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intake is first converted to acetaldehyde by alcohol dehydrogenase, which will be further 
oxidized to acetic acid through the coupling reaction of ALDH (Riveros-Rosas et al, 
1997). 
Nowadays, more and more evidence suggest that ALDHs perform multiple 
functions. Aside from their catalytic properties, ALDH are capable of non-catalytic 
interactions. ALDHlAl has been identified as an androgen-binding protein in human 
genital fibroblasts and as a cholesterol-binding protein in bovine lens epithelium 
(Vasiliou et al., 2004). ALDH2 also display binding capabilities with exogenous 
compounds like acetaminophen (Vasiliou et al., 2000). ALDH3A1 and ALDHlAl play 
critical roles in cellular homeostasis by maintaining redox balance through the 
generation of NADH and NADPH (Uma et al., 1996). These molecules possess 
antioxidant capacity. For example, NADPH is involved in the regeneration of reduced 
glutathione from its oxidized form via the glutathione reductase/peroxidase system. The 
multi-functional properties of ALDH also extend to structural function. ALDHS A1 and 
ALDHlAl which are highly expressed in mammalian cornea and lens crystallins, are 
suggested to contribute to transparency of the structure (Piatigorsky, 2001; Jester et al, 
1999). Furthermore, recent findings on ALDH3Al，s effect on cell proliferation support 
the diversity of ALDH functions (Pappa et ai, 2005; Estey et al, 2007). A reduction of 
ALDH3A1 gene expression is noticed in actively proliferating primary human corneal 
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epithelium explant cultures (Pappa et ai, 2005). The role of ALDH3A1 as a negative 
cell cycle regulator is demonstrated in ALDH3Al -transfected cells exhibiting an 
elongated cell cycle, decreased plating efficiency, and reduced DNA synthesis 
compared with the mock-transfected cells. These effects were associated with 
reduced cyclin A- and cyclin B-dependent kinase activities and reduced 
phosphorylation of the retinoblastoma protein as well as decreased protein levels of 
cyclins A, B, and E, the transcription factor E2F1, and the cyclin-dependent kinase 
inhibitor p21. These proliferation-suppressive functions, together with the metabolic 
function of ALDH3A1, confer protection to corneal epithelial cells against oxidative 
damage. 
As mentioned above, aldehydes are highly reactive molecules that are 
intermediates or products involved in a broad spectrum of physiologic, biologic, and 
pharmacologic processes; mutations in several ALDH genes are often the molecular 
basis of inborn errors of metabolism (Vasiliou et al, 2004). The variant alleles encode 
defective enzymes with low or no catalytic activity, resulting in the disease 
phenotype. 10-FTHFDH, also known as ALDHILI, hydrolyzes 
10-formyltetrahydrofolate to tetrahydrofolate (Krupenko et al,, 1997). Folate enzymes 
catalyze the biosynthesis of nucleotides and are critical for cell proliferation 
(Krupenko & Oleinik, 2002). Loss of the capacity for folate metabolism has deleterious 
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effects on cells, manifesting reduced cell growth (Borman & Branda, 1989) and 
impairment of cell division (Cook et al, 1991). ALDH3A2, which is constitutively 
expressed in all tissues, catalyzes the oxidation of fatty aldehydes derived from 
metabolism of fatty alcohol, phytanic acid, ether glycerolipids and leukotriene B4 
(Kelson et al,, 1997). Loss of ALDH3A2 function is the molecular basis underlying 
Sjogren-Larsson syndrome, an autosomal recessive disorder characterized by congenital 
ichthyosis, mental retardation, spasticity, ocular abnormalities and pruritus (Willemsen 
et al,’ 2001; Gordon, 2007). Moreover, ALDHs are also involved in amino acid 
metabolism, which will be more deeply discussed Chapter 4. 
1.1.3 Structural Organization of Aldehyde Dehydrogenases in view of 
their Catalytic Mechanism 
Before crystallographic information was available, identification of critical 
residues involved in aldehyde oxidation depended mainly on chemical modification 
and site-directed mutagenesis. ALDH2 was usually used as the model for study. The 
presence of catalytic thiol C302 in the enzyme active site has been demonstrated by 
chemical modification (Pietruszko et al., 1991) as well as site-directed mutagenesis 
(Farres et al., 1995). Besides, E268 has been identified as the general base that interacts 
with the active site cysteine or water during enzyme catalysis (Wang & Weiner, 1995). 
The catalysis is referred to an irreversible, compulsory order mechanism, with NAD+ 
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first bound to the enzyme. The aldehyde substrate then binds to the enzyme-cofactor 
complex. The catalytic mechanism of ALDH has been proposed to be similar to that of 
G3PDH (Feldman & Weiner，1972), in which the oxidation of aldehyde occurs in 2 steps. 
As a nucleophile, a cysteine residue first attacks the carbonyl group of the substrate 
aldehyde to form a thiohemiacetal intermediate. This covalent adduct is then oxidized to 
a thioester upon hydride transfer. The cofactor NAD+ represents the hydride recipient 
which forms an acyl enzyme as a result (Farres et <7/., 1995). The rate-limiting step of the 
reaction is the activation of a water molecule; the activated water then performs a 
nucleophilic attack on the acyl-sulphur bond to release the acid and allow NADH 
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(Mami & Werner. 1995) 
Advances in X-ray crystallography technology facilitate the understanding of 
proteins in the past decade. The first crystal structure of human ALDH3 allows a first 
look at a member of the ALDH family in atomic detail. The enzyme is found to be a 
homodimer (Liu et al., 1997)，an arrangement which is actually not very common 
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among ALDHs. Instead, most functionally active ALDHs exist as homotetramers. 
Structures of different families of ALDH are then reported successively, including 
bovine ALDH2 (Steinmetz et ai, 1997), cod betaine ALDH (Johansson et al.’ 1998), 
sheep ALDHl (Moore et al., 1998), Escherichia coli YdcW (Gruez et al, 2004), 
Thermus thermophilus A‘-pyrroline-5-carboxylate dehydrogenase (Inagaki et al., 
2006), Streptococcus mutans non-phosphorylating G3PDH (D'Ambrosio et al, 2006), 
E.coli lactaldehyde dehydrogenase (Di Costanzo et al., 2007) as well as rat 
10-FTHFDH (Tsybovsky et al, 2007). Despite differences in the amino acid 
sequence, substrate specificity and physiological function, the overall folding of the 
monomer is similar. Each subunit contains an NAD+ binding domain, a catalytic 
domain and an oligomerization domain as shown in Figure 1.2. Both the NAD+ 
binding and catalytic domains adopt the /3-a-^ type of secondary structure, while 
the oligomerization domain is solely comprised of /3 -sheets. Dimer formation takes 
place between a -helices and (3 -sheet extension between the catalytic and 
oligomerization domains of monomers (Liu et al., 1997; Steinmetz et al., 1997). 
Different dehydrogenases utilize different dinucleotides like NAD+ and FAD as 
their cofactors. Nucleotide-binding domain of an enzyme usually follows either 
Rossmann fold (Rossmann et al, 1974; Wierenga et al., 1986) or a / / 5 barr el folding 
(Hoog et al., 1994; Wilson et al., 1992). ALDH's nucleotide binding domain follows 
9 
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Figure 1.2 Ribbon representation of the Thermus thermophilus 
A^-pyrroline-5-carboxylate dehydrogenase subunit with bound NAD+ and glutamate 
(Inagaki et al, 2006). 
The coenzyme-binding domain is colored gray and cyan. The catalytic domain is 
colored green and the oligomerization domain is in yellow. Ball and stick models 
represent the NAD+ (magenta) and the glutamate (black). 
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Figure 1.3 Ribbon diagram showing the organization of a -helices and JB -sheets in 
a typical Rossmann fold present in the structure of horse liver alcohol dehydrogenase 
(Cedergren & Zeppezauer, 1983). 
a -helices and (3 -sheets are colored in red and cyan respectively. 
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the Rossmann fold arrangement. However, the binding mode is novel since there are 
some modifications with the typical Rossmann fold. The fold is made up of 5 
-sheets with 4 a -helices in between (Liu et al, 1997), instead of 6/3-sheets in the 
typical fold (Figure 1.3). The fingerprint sequence GXGXXG which is often found at 
the first /5 a loop (Wierenga et al, 1986) is also replaced by a glycine-rich GXXXXG 
sequence on a E which is conserved in the ALDH superfamily (Liu et al., 1997). As a 
result, the close contact between the first a -helix of the Rossmann fold and the 
pyrophosphate group of the coenzyme brought about by the motif is absent in the 
structure of ALDH (Liu et al., 1997). 
Two different conformations of NAD+ can be identified from various binary 
structures. A number of them are in "hydride transfer" conformation; while the others 
are in "hydrolysis" conformation with the nicotinamide ring positioned out of the active 
site brought about by rotation at the pyrophosphate bond (Figure 1.4). The 2 
conformations can even co-exist in a single structure of ALDHl (Moore et ai, 1998) and 
ALDH2 (Ni et al., 1999). These 2 conformations differ mainly in the position of the 
nicotinamide ring while the adenine ring is relatively stable. The mobility of the 
nicotinamide half of the coenzyme is a unique feature of ALDH crystal structures. It is 
usually indicated by missing or weak electron density for the nicotinamide ring and 
ribose and consequently high temperature factors compared with surrounding protein 
12 
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Figure 1.4 Stereodiagrams of active site configurations seen in human ALDH2. 
Panel A refers to the hydride transfer conformation; while panel B refers to 
hydrolysis conformation (Perez-Miller & Hurley, 2003). 
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residues (Ahvazi et al, 2000; Cobessi et al, 1999). It was proposed that pyrophosphate 
bond rotation would occur during catalysis (Steinmetz et al., 1997). Recently, the first 
structure of G3PDH thioacylenzyme intermediate also reveals that reduction of the 
cofactor upon acylation leads to an extensive motion of the nicotinamide moiety with 
a flip of the reduced pyridinium ring away from the active site without significant 
changes of the protein structure (D'Ambrosio et al., 2006). 
In tetrameric enzymes, the active sites lie at the end of a deep hydrophobic tunnel 
(Moore et al,, 1998; Ni et al, 1999). The side chain of the catalytic cysteine protrudes 
into the center of the tunnel extending through the catalytic domain (Liu et al, 1997; 
Steinmetz et a!.,1997). 
14 
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1.2 Antiquitin 
1.2.1 Discovery and Plant Antiquitins 
The cDNA clone of antiquitin (ATQ) was first discovered in 1990 incidentally 
in which its poly(A) RNA level was found to be increased upon pea shoot 
dehydration (Guerrero et al, 1990). The regulation was at transcriptional level and 
was reversible. The 26g pea tugor protein encoded a 508 amino acid protein with 
30% residue identity to several ALDHs. Later it was classified as ALDH family 7 
(Vasiliou et al., 1999). 
This protein regained scientists' attention when a human homolog was 
discovered during screening of a rat mucosa cDNA subtraction library (Lee et cd., 
1994). The human protein shared �6O0/0 homology (Figure 1.5) with its plant 
counterparts and was named "Antiquitin" because of its remarkable level of 
conservation throughout evolution. 
Following these findings was a number of publications concerning the 
turgor-responsiveness of plant ATQs. Up-regulation of ATQs was observed in canola 
leaf (Stroeher et al, 1995) as well as barley leaf and root (Ozturk et al, 2002) after 
drought. Inducibility of plant ATQ was also demonstrated in canola since high 
salinity, low temperature, heat shock and the plant hormone abscisic acid could 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 1 Introduction 
observed for Arabidopsis (Kirch et al, 2001). On the other hand, ATQ level rose 
during the enlargement stage of apple fruit development, when sugar and water 
accumulated rapidly to boost the osmotic pressure within the fruit cell (Yamada et al., 
1999). Arabidopsis and tobacco plants ectopically expressing the soybean ATQ-like 
ALDH7 gene were found to display enhanced tolerance to drought, salinity, and 
oxidative stress (Rodrigues et al, 2006). Recent findings suggested that ATQ might 
work together with catalase and represent additional nodes in the Euphorbia defense 
systems, and participated in a multi-enzymatic interaction contributing to plant's 
protection against biotic and abiotic stresses (Mura et al” 2007). Therefore it is 
sensible to conclude that plant ATQ is largely involved in cellular turgor pressure 
regulation by synthesis of osmoprotectants or removal of toxic aldehydes formed 
during water deficit. 
1.2.2 Animal Antiquitins 
In view of the striking similarity of plant and human ATQs (ALDH7A1), it is 
possible that human ATQ might also function as a regulator of fluid balance. It was 
also reported that human ATQ was highly expressed in kidney and cochlea outer hair 
cells (Skvorak et al., 1997). Nevertheless, ATQ did not seem to be the causative gene 
for Meniere Disease, an idiopathic disorder of the inner ear, since no mutations in the 
17 
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gene could be detected in the patients (Lynch & Cameron, 2002). 
Furthermore, human ATQ was not inducible as expected. Early in its discovery, 
attempts to induce its mRNA by heat-shock, dehydration, irradiation and other 
stresses were not successful (Lee et al., 1994). Later study in human embryonic 
kidney cell line also revealed that osmotic and oxidative stresses did not alter ATQ 
mRNA level (Wong et al； 2005). 
Besides involvement in osmoregulation, ATQ was also suspected to take part in 
cell growth and development (Fong et al., 2006). ATQ mRNA failed to express in 
phosphatidylinositol glycan class A (PIG-A) mutant cells (Kanai et al, 1999). PIG-A 
mutations are well known to lead to the development of paroxysmal nocturnal 
hemaglobinuria, a hemolytic disorder in which the patient's erythrocytes suffer 
complement-induced injury (Rosse, 1990). It was suggested that difference in the 
gene expression pattern could influence the proliferative properties of the PIG-A 
mutant cells through the action of downstream proteins like ATQ. ATQ protein level 
was significantly increased in the MI and Mil stages of in vitro maturation of pig 
oocyte (Ellederova et al., 2004), which allow the formation of fully matured oocytes 
that were capable of undergoing fertilization and subsequent zygotic development. 
18 
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1.2.3 Human Antiquitin Gene Mutations and Pyridoxine-dependent 
Seizures 
Recently, the indispensable role of human ATQ became clear. It was reported 
clinically that mutations in the ALDH7A1 gene on chromosome 5q31 were 
associated with PDS (Mills et al., 2006). PDS is an autosomal, recessively inherited 
inborn error of metabolism. PDS patients suffer from recurrent long-lasting seizures, 
pyridoxine is often administered to prevent convulution. ATQ was identified as an 
a -aminoadipic semialdehyde ( a -AASA) dehydrogenase. It oxidized a -AASA from 
lysine metabolism into a -aminoadipate ( a -AAA), the salt of its corresponding acid. 
In PDS patients, mutations in the antiqutin gene resulted in a defective or even 
non-functional enzyme that failed to perform its normal oxidative role. This would 
lead to the accumulation of the enzyme's substrate a -AASA, as well as its 
equilibrium product piperideine-6-carboxylate (P6C). P6C would in turn undergo 
Knoevenagel condensation with pyridoxal 5'phosphate (PLP). PLP inactivation 
finally caused seizures as it was an essential cofactor for reactions involved in 
neurotransmitter metabolism. Therefore patients of PDS with homozygous ATQ 
mutations would suffer severe cognitive deficits (Rankin et al, 2007). 
Later molecular analysis continued to identify 10 novel mutations within highly 
conserved regions of the ATQ gene (Plecko et al., 2007). One of the mutations, Glu 
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399 Gin, was found with marked prevalence within the cohort. The role of ATQ in 
central nervous system was further supported by its differential expression in the 
hippocampus of Ras-guanine-nucleotide-releasing factor 1 (Ras-GRFl) knockout 
mice (Fernandez-Medarde et al., 2007). Its level affected signal transduction 
pathways related to memory and learning and explained the potential functional link 
of Ras-GRFl to neurodegenerative processes. 
1.2.4 Previous Findings on Seabream Antiquitin 
In our laboratory, previous work had been done on seabream ATQ to investigate 
its functional role. In silico analysis of the seabream ALDH7 promoter region did not 
reveal any osmotic response element. Instead, it contained potential binding sites for 
cell cycle related cis-elements such as CCAAT displacement protein and cell 
cycle-dependent element/cell cycle genes homology region (Chan et al” 2006). The 
first purification and characterization of seabream ATQ revealed that the protein was 
a tetramer with subunit molecular weight of 57500 (Tang et al, 2002). The native 
enzyme preferred NAD+ as the cofactor and possessed oxidizing activity towards 
aliphatic and aromatic aldehydes. ATQ was found to be highly expressed in both 
seabream kidney and liver (Tang et al, 2005). Later, grass carp ATQ having similar 
physical and kinetic properties as the seabream enzyme was also purified (Chan et al., 
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2003). Subsequently, the full-length cDNA sequence of seabream ATQ had been 
cloned and it was demonstrated to be a cytosolic protein. Purified recombinant 
seabream ATQ exhibited similar kinetics properties as the native enzyme (Tang et al” 
2005). 
The crystal structure of seabream ATQ / NAD+ binary complex had been solved 
to 2.8 A (Tang et al； unpublished). The asymmetric unit contained two tetramers of 
ATQ, each existed as a dimer-of-dimer. This arrangement was common for many 
families of ALDHs. Each monomer was comprised of three domains, namely 
NAD+-binding domain, catalytic domain and oligomerization domain. The bound 
NAD+ in seabream ATQ was in the "hydride-transfer" conformation. At the mouth of 
the pocket, there was a pair of oppositely charged residues, Glul20 and Arg300, 
playing critical roles in determining the substrate specificity of ATQ. Kinetics data 
and structural information together suggested that Glul20 was involved in stabilizing 
the enzyme-substrate complex through charge-charge interaction with the positively 
charged a-amino group of the substrate; while Arg300 was involved in stabilizing 
the transition state during the catalytic process but not in substrate binding through 
interactions with the a-carboxylate group of a-AASA. 
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1.3 Aims of Study 
ATQ, or ALDH7, is a newly emerged family of ALDH which has not been as 
well studied as conventional ALDHl or ALDH2 in the aspect of detoxification. Since 
its first discovery in 1990, publications focused on discussing the role of the plant 
protein in osmoregulation. Little information about ATQ in mammals was available, 
and most of them only gave a touch on the protein during library screening or profile 
studies. However, due to the high homology of ATQs in the 2 Kingdoms, it is 
undoubtedly that the protein is actually playing an indispensable role for an organism 
to survive. Our group initiated study on this enzyme, trying to investigate its core 
physiological functions in vertebrates, and eventually humans. From purifying and 
characterizing native enzymes from the liver of black seabream and grass carp, to 
promoter studies and then production of recombinant seabream protein for 
3-dimensional structure determination, better understanding of this enzyme could be 
achieved. Effort had been put to search for the identity of the physiological substrate 
of ATQ, which in turn, might give a hint on its functions. 
A turning point was the discovery of correlation between ATQ gene mutations 
and pyridoxine-dependent seizures (PDS). This finding had driven scientists to first 
gaze on this mysterious but important family of ALDH. Recently, several papers 
concerning mutations in PDS patients and ATQ's role in nervous system have been 
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published. Our laboratory had also made use of the seabream crystal structure and 
mutants to explain the disease-related mutations. Although human and seabream 
ATQs share 85% amino acid sequence homology and the fish model might be good 
enough for analysis, it is worthy for us to step forward to the level of human since 
this will provide us the most suitable platform to explain the whole picture. No 
recombinant human ATQ protein has been characterized kinetically, not to mention 
the PDS-related mutants of the enzyme. Structural information was also limited to 
ATQ/NAD+ binary complex (Bunkoczi et al, unpublished; PDB: 2J6L). 
Therefore this project was launched to first, subclone the full-length cDNA of 
human ATQ into pRSETA for protein expression in E.coli. After purifying the 
recombinant protein by chromatography, information on protein's molecular weight, 
optimal pH for activity, stability in different temperatures and pH, together with 
substrate specificity, could be obtained. The recombinant protein would also be 
utilized to form protein crystals for structure determination purpose. The second part 
of this project was to prepare a series of human ATQ mutants by site-directed 
mutagenesis. Purified enzyme mutants were subjected to kinetic studies. These data, 
together with the crystal structure of the wild-type enzyme, could be used to explain 
why certain point mutations in the ATQ gene would lead to the onset of PDS. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 Subcloning, Expression and Purification of Human Antiquitin 
The primers were obtained from Tech Dragon Ltd., Hong Kong. The 
polymerase chain reaction (PGR) buffer and the PfuTurbo® DNA polymerase were 
from Stratagene, U.S. Vector pRSETA was from Invitrogen, U.S.. The QIAquick® 
gel extraction kit and QIAprep® spin miniprep kit were products of Qiagen, U.S. The 
restriction enzymes Ndel, EcoRI, the corresponding digestion buffer 4; as well as the 
T4 DNA ligase and its buffer were purchased from New England Biolabs, U.S. 
BL21(DE3)pLysS was from Merck Biosciences, Germany. Ampicillin, 
chloramphenicol, agar, ethylenediaminetetraacetic acid (EDTA)， 
phenylmethylsulfonylfluoride (PMSF), sodium chloride and P-nicotinamide adenine 
dinucleotide sodium salt (NAD+) were from Sigma, U.S. Dithiothreitol (DTT) and 
benzamidine were products of Sigma-Aldrich, U.S. Luria-Bertani (LB) broth and 
potassium phosphate (monobasic anhydrous) were USB products from GE 
Healthcare, Singapore. Difco® SOB broth was purchased from Becton, Dickinson 
and Company, France. Isopropyl-P-D-thiogalactopyranoside (IPTG) was obtained 
from Shenergy Biocolor Bioscience & Technology Company, China. Affi-gel® blue 
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gel and protein assay dye reagent concentrate were from Bio-Rad, U.S. All chemicals 
were of analytical grade. Amicon® stirred cells and YM 10 ultrafiltration membrane 
were purchased from Millipore, U.S. 
2.1.2 Characterization of Human Antiquitin 
Tris，SDS and glycerol were USB products from GE Healthcare, Singapore. 
Acrylamide, ammonium persulfate and the silver staining kit were purchased from 
Bio-Rad, U.S. N,N,N',N'-Tetramethylethylenediamine (TEMED), bromophenol blue, 
/3 -mercaptoethanol, Coomassie Brilliant Blue G, HEPES, sodium pyrophosphate, 
glycine, propionaldehyde, 3 -nitrobenzaldehyde and o-aminobenzaldehyde were from 
Sigma, U.S. Centricon® centrifugal filter units were purchased from Millipore, U.S. 
The molecular weight calibration kit, lEF 3-9 gel, lEF sample applicators, the 
isoelectric point (pi) calibration kit and the Pharmacia Biotech Superdex 200 column 
were obtained from GE Healthcare, Singapore. NAD+ and amberlyst-15 resin were 
purchased from Sigma-Aldrich. Benzaldehyde was a product of Aldrich，U.S. 
Acetaldehyde was from Merck-Schuchardt, Germany. Allysine ethylene acetal was 
obtained from Chiralix, Netherlands. 
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2.1.3 Crystallization of Human Antiquitin, Diffraction Data 
Collection and Structure Determination 
NADH was from Sigma, U.S. Acrodisc® syringe filter was a product of Pall 
Corporation, U.S. Index™ crystallization screen kit, Crystal Screen HT^"^ kit, Additive 
ScreenTM，Cryschem plates and clear sealing tape were products from Hampton 
Research, U.S. BIS-TRIS, ammonium sulfate, calcium chloride dihydrate and 
Polyethylene glycol 550 monomethyl ether (PEG MME 550) were products from Fluka, 
Germany. 
2.1.4 Mutational Studies of Human Antiquitin 
The QuikChange® II site-directed mutagenesis kit was purchased from 
Stratagene，U.S., which included lOX reaction buffer, dNTP, PfuUltra'^^ HF DNA 
polymerase (2.5 U/ul), restriction enzyme Dpnl (10 U/ul) and the XL-1 Blue 
Supercompetent cells. The Superdex 75 column was product of Pharmacia Biotech 
obtained from GE Healthcare, Singapore. 
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2.2 METHODS 
2.2.1 Subcloning, Expression and Purification of Human Antiquitin 
2.2.1.1 Subcloning of the Full-length Human Antiquitin cDNA 
Using the commercially available pDNA-Dual/huATQ plasmid (Open 
Biosystems GH00232L1.0) as the template, the 5' end and 3' end of the entire coding 
region were amplified by using a pair of ATQ specific forward primer 
5，-TGAGCCCATATGTCCACTCTCCTCAT-3’ and reverse primer 
5 ’ -GGCTCAGAATTCTTACTGAAACTTGA-3 ’. The primers were designed 
according to the human ATQ sequence (GenBank BT007823). The underlined 
hexamer sequences indicate Ndel and EcoRI restriction sites, respectively, which 
facilitate subsequent cloning of the PGR product. An end clamp of 6 nucleotides 
(TGAGCC) is introduced into the 5' position of the primers to facilitate docking of 
restriction enzyme onto the PGR product for digestion. 
PGR was performed in GeneAmp® PGR System 9700 (Applied Biosystems) to 
amplify the huATQ construct. In each reaction, 1 ul of 10 mM dNTP, 5 ul lOx PGR 
buffer, 1 ul forward (10 pmol/ul) and 1 ul reverse primer (10 pmol/ul), 1 ul 
pDNA-Dual/huATQ template and 1 ul of PfuTurbo® DNA polymerase (2.5 U/ul) 
were added and the mixture was made up to 50 ul with sterile deionized distilled 
water (ddH20). PGR was started by a 2 minute incubation at 9 4 � C followed by 25 
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cycles of incubation as follows: 94 °C for 30 seconds, 52 °C for 30 seconds, 7 2 � C for 
1 minute 45 seconds. The reaction was stopped after a further incubation at 7 2 � C for 
10 minutes. The PCR product was visualized in a pre-stained 1.2% agarose gel and 
then purified by the QIAquick® gel extraction kit. 
The recovered PCR product and pRSETA vector were digested with 0.5 ul of 
Ndel (20000 U/ml) and EcoRI (20000 U/ml) in lOx digestion buffer 4 in a reaction 
volume of 40 ul and 15 ul respectively at 37°C overnight. The restricted product was 
purified by QIAquick® gel extraction kit. Ndel and EcoRl digested pRSETA was 
ligated with the huATQ insert containing compatible ends in a mass ratio of 1:3 in 
order to generate the pRSETA/huATQ plasmid. For each reaction, 1 ul (400000 
U/ml) of T4 DNA ligase was used in lOx ligation buffer. Sterile ddH20 was added to 
make up the reaction volume to 25 ul. Ligation was carried out at 16 °C overnight. 
One ul of ligation product was added to frozen competent cell of strain DH5a 
and placed on ice for 30 minutes. Heat-shock transformation was performed by 
placing the tube into a 42 °C heat block for 1 minute 45 seconds and returning them 
immediately on ice for 2 minutes. The transformed E.coli was recovered by 
incubating at 37 °C for 60 minutes with shaking at 250 rpm, with total volume made 
up to 1 ml by LB medium. The recovered cells were then spread onto LB-Ampicillin 
(50 ug/ml) agar plate and incubated at 37 °C for 16-18 hours. Bacterial colonies 
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formed were picked and grown to an overnight culture. DNA plasmid was extracted 
⑧ 
by QIAprep spin miniprep kit and was screened for the presence of recombinant 
plasmid by enzyme restriction. Positive clones were fully sequenced by Tech Dragon 
Ltd. using the vector primers (T7 for the 5' end and T7 term for the 3’ end) and the 
gene specific primer huATQ-rev-1096 5 ‘ -TGCCACCTTCTTTCTTTGCT-3 ‘ (reverse 
primer) targeting to the nucleotide 1096 in the open reading frame. Sequence 
alignment was performed using the online ClustalW program (Thompson et al., 
1994). 
2.2.1.2 Bacterial Expression of Recombinant Human Antiquitin 
The recombinant plasmid pRSETA/huATQ was transformed into 
BL21(DE3)pLysS cells for expression purpose. The procedures were similar to those 
described above. Prior to the day of expression, an overnight culture of the 
transformed cell was grown in 15 ml SOB broth containing ampicillin (50 ug/ml) and 
chloramphenicol (20 ug/ml) at 37 °C for 16-18 hours, with shaking at 250 rpm. An 
appropriate amount of the overnight culture was poured into flask containing fresh 
SOB medium in order to attain an initial ODeoo of 0.1. The flask was returned to the 
incubator for shaking at 37 °C, with ODeoo being constantly monitered in a 
spectrophotometer. When the reading reached 1, induction was carried out by adding 
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IPTG to a final concentration of 0.1 mM. 
After an overnight shaking at 37° C, the cells were harvested by centrifuging at 
8000 rpm at 4 � C for 20 minutes. Medium was discarded, while the pellet was 
resuspended in buffer of 30 mM potassium phosphate and 1 mM EDTA, pH 6.0, with 
1 mM DTT and 2 mM benzamidine added just before use. The resuspended 
bacteria were lysed by sonication for 5 times at 20 second interval in the presence of 
PMSF. After that, the cell lysate was ultra-centrifuged at 35000 rpm at 4 � C for 1 
hour 15 minutes and the supernatant was saved. 
2.2.1.3 Purification of Human Antiquitin 
The supernatant obtained was assayed for protein concentration by Bradford 
assay. The acetaldehyde-oxidizing activity was also checked. Fifteen mg of lysate 
protein was applied to a 30 ml column (1.7 x 15 cm) of Affi-gel® blue gel equilibrated 
with the resuspension buffer by BioLogic LP system (Bio-Rad) at 0.5 ml/minute. 
The column was washed with 1 M sodium chloride in buffer, followed with 5 mM 
NAD+ in buffer. Finally, the recombinant huATQ was eluted with buffer containing 
both 1 M sodium chloride and 5 mM NAD+. The peak fractions of 
acetaldehyde-oxidizing activity were pooled and concentrated by ultrafiltration using 
Amicon® stirred cells with YM 10 ultrafiltration membrane. The whole purification 
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procedure was carried out at 4 For performing lEF, stability studies and 
determination of Km for the enzyme towards NAD+, the eluted proteins were first 
dialyzed against 30 mM potassium phosphate and 1 mM EDTA, pH 6.0 for 2 
successive days. 
2.2.2 Characterization of Human Antiquitin 
2.2.2.1 Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
The 12% resolving and 5% stacking gels were prepared according to literature 
(Laemmli & Favre, 1973) and casted in the Mini-PROTEAN® II electrophoresis cell 
(Bio-Rad). Samples were diluted with 4X sample loading buffer (20% glycerol (v/v), 
4% SDS (w/v), 0.005% bromophenol blue (w/v) and 5% /3 - mercaptoethanol (v/v) 
in 1.5 M Tris-HCl, pH 6.8). The samples were boiled for 10 minutes and cooled to 
room temperature before being loaded onto the polyacrylamide gel. Electrophoresis 
was performed at a constant voltage of 160 V at room temperature. When the 
tracking dye reached the bottom of the gel, electrophoresis was terminated. The gel 
was stained with 0.05% Coomassie Brilliant Blue G in acetic acid/ methanol/ water 
in the ratio of 1:3:10 and destained with the same solvent base until the background 
was clear. The subunit molecular weight of the protein was estimated by using the 
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molecular weight calibration kit comprised of phosphorylase b (97.0 kDa), bovine 
serum albumin (66.0 kDa), ovalbumin (45.0 kDa), carbonic anhydrase (30.0 kDa), 
soybean trypsin inhibitor (20.1 kDa) and a - lactabumin (14.4 kDa). 
2.2.2.2 Size-exclusion Chromatography - Multi-angle Light Scattering 
(SEC-MALS) 
The eluted protein was concentrated to 5 mg/ml using Amicon® stirred cells and 
Centricon®-10 centrifugal filter units. It was then centrifuged at 7000 rpm, 4°C for 5 
minutes to remove precipitate. 
The SEC-MALS system was comprised of a miniDAWN^^ light scattering 
detector (Wyatt) connecting to an AKTApurifier system (Pharmacia Biotech) with a 
Superdex 200 column. The column was equilibrated with 30 mM potassium 
phosphate, 1 mM EDTA, pH 6.0, 0.2 M sodium chloride, at 0.5 ml/minute. Protein 
sample was first fractionated by column chromatography, with the separated 
molecules eluted to a MALS detector connected on-line. The molar weight of the 
protein sample was measured directly. On the other hand, there was also an Optilab® 
DSP refractive index detector (Wyatt) in series with the MALS for concentration 
detecting purpose. Data analysis was performed by the ASTRA® 5.1.9 software 
(Wyatt). 
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2.2.2.3 Isoelectric Focusing (lEF) 
lEF was performed using the PhastSystem (GE Healthcare) with precast lEF 3 -
9 gel according to manufacturer's instructions. After focusing, proteins were stained 
with silver staining kit. The gel was first fixed with 50% ethanol, 10% acetic acid 
and 10% fixative enhancer for 20 minutes, followed by 2 washing steps using 
ddHzO. The gel was then stained with a mixture of silver complex, reduction solution 
and image developer in an appropriate proportion as suggested by the company. The 
pi value of the protein was estimated by using the pi calibration kit comprised of 
P -lactoglobulin A (pi = 5.2), bovine carbonic anhydrase B (pi = 5.85), human 
carbonic anhydrase B (pi = 6.55), horse myoglobin acidic (pi = 6.85) and horse 
myoglobin basic (pi = 7.35). 
2.2.2.4 pH-rate Profile 
The aldehyde-oxidizing activity of the enzyme was determined by measuring 
the initial rate of NADH production at 340 nm by an Ultrospec 3000 
spectrophotometer (Amersham Bioscience), using an extinction coefficient of 6220 
for NADH. The assay was conducted in 0.1 M buffer at 25°C. One unit 
of dehydrogenase activity refers to the production of 1 umole of NADH per min. 
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0.1 M HEPES (pH 6-8), sodium pyrophosphate (pH 8-10) and glycine-NaOH 
(pH 10-11) containing 2.5 mM NAD+ and 14 mM acetaldehyde were used to perform 
the assay. At pH of buffer change, overlapping points of activity were obtained using 
both buffers. Aldehyde-oxidizing activity was represented in % activity relative to 
the pH giving the highest activity. 
2.2.2.5 Stability Studies 
A pre-incubation step of 10 minutes was involved in this study. For temperature 
stability study, recombinant enzyme was first incubated at different temperatures in a 
mixture of 0.1 M HEPES, pH 7.5 both in the presence or absence of NAD+ at a final 
concentration of 2 mM before activity assay was carried out. The total volume of 
incubation mixture is 50 ul, comprised of majority the incubation buffer and a small 
volume of concentrated enzyme and NAD+ (if necessary). Typical assay was 
conducted using 0.1 M sodium pyrophosphate, pH 9.5 containing 2.5 mM NAD+ and 
14 mM acetaldehyde. Forty ul of the incubation mixture was transferred to the 
cuvette for measurement. 
Similarly, for pH stability study, the enzyme was pre-incubated in 0.1 M HEPES 
(pH 6-8) and O.IM sodium pyrophosphate (pH 8-10) with or without 2 mM NAD+ at 
room temperature for 10 minutes. At pH of buffer change, overlapping points of 
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activity were obtained using both buffers. Typical dehydrogenase activity assay was 
conducted as before. 
2.2.2.6 Substrate Specificity Study 
The enzyme activity assay for all substrates, except a-AASA, was conducted in 
0.1 M sodium pyrophosphate, pH 9.5 containing 2.5 mM NAD+ as mentioned before. 
For the assay of a-AASA activity, O.IM MOPS, pH 7.8 containing 2.5 mM NAD+ 
was used to minimize background activity. 
As a-AASA was not commercially available, it was prepared according to the 
method suggested in a chemical literature (Rumbero et al., 1995). Allysine ethylene 
acetal (18.9 mg) was first dissolved in 1 ml ddHaO, followed by the addition of 40 
mg amberlyst-15 resin. The mixture was left at room temperature for 10 minutes for 
a-AASA production, which was in equilibrium with P6C. In order to determine its 
concentration, 200 ul of the supernatant was allowed to react with 10 ul of 0.4 M 
a-aminobenzaldehyde (Soda et al., 1968) for an hour at 37°C, with the final volume 
made up to 1.2 ml by 0.1 M MOPS, pH 7.8. The concentration of a-AASA was 
determined at 465 nm by using an extinction coefficient of 2800 M'^ cm"^ 
To measure kinetic parameters for the enzyme's cofactor NAD+, 0.1 M MOPS, 
pH 7.8 containing a final concentration of 0.6 mM a-AASA was used. 
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2.2.3 Crystallization of Human Antiquitin, Diffraction Data 
Collection and Structure Determination 
2.2.3.1 Crystallization of Human Antiquitin 
The purified protein was overnight-dialyzed against 10 mM HEPES, pH 7.0 
containing 1 mM NADH, avoiding light illumination. The protein was then filtered 
through Acrodisc® syringe filter with a 0.2 uM membrane and concentrated to 10 
mg/ml using Amicon® stirred cells and Centricon®-10 centrifugal filter units. Prior to 
crystallization, the protein was centrifuged at 7000 rpm, 4°C for 5 minutes to further 
remove precipitate. 
Initial screening for the crystallization conditions was performed with Index^"^ 
crystallization screen kit and Crystal Screen HT^'^ kit in a 96-well plate format. Crystals 
were grown using sitting-drop vapour diffusion method at 289 K. Each reservoir was 
filled with 100 ul of the crystallization reagent supplied. One ul of the mother liquor was 
mixed with 1 ul of a 10 mg/ml protein solution in the small well over the reservoir. The 
reservoirs were then sealed with special crystallization tape for attaining equilibrium. 
Crystal formation was monitored under microscope after 1 day, 2 days, 3 days and a 
week after the start of screening process. The sparse matrix screening tested unique 
combinations of pH，salts, precipitants for their ability to promote crystal growth. 
When crystals were obtained, solubility information could be used to optimize 
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crystallization conditions to produce crystals suitable for x-ray diffraction analysis. 
Two potential crystallization conditions were chosen for subsequent grid screen. 
Usually, 5X buffers of different combinations of precipitant concentration and pH in 
an appropriate range were prepared and filtered to remove impurities. In each well of 
the 24-well plate, 2 ul of protein sample was mixed with the same volume of mother 
liquor and equilibrated over 500 ul of reservoir solution. The grid process was repeated 
for a finer range of precipitant concentration and pH until protein crystals of good 
quality were obtained for diffraction purpose. Crystals were finally obtained by vapor 
diffusion at 289K from droplets containing protein solution and precipitant solution 
of 0.1 M BIS-TRIS, pH 6.4，0.05 M calcium chloride dihydrate, 23% v/v PEG MME 
550. 
Presence of additives may improve the quality of the crystal. Therefore Additive 
ScreenTM i，2,3 were employed to search for better conditions for crystal formation. 
The procedures were similar to normal grid screen, except that 0.5 ul of different 
additives was added to the protein-precipitant mixture. For volatile additives, the 
reservoir should also contain the additive as well. 
2.2.3.2 Diffraction Data Collection and Model Building 
After optimization, larger-sized crystals which were in good conditions were 
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chosen for diffraction. In order to obtain the hu ATQ/N ADH/a-A A S A ternary complex, 
the crystals were first soaked in mother liquor containing 1 mM of a-AASA for 2 hours. 
The crystals were loop-mounted and transferred directly into the cryostream at 11 OK. 
X-ray diffraction data was finally collected from a crystal formed in 0.1 M BIS-TRIS, 
pH 6.4, 0.05 M calcium chloride dihydrate, 23% v/v PEG MME 550 with an additive 
of 0.3 M glycyl-glycyl-glycine, using the MicroMax-007 generator (Rigaku) at the 
Centre of Proteins and Crystallography, Department of Biochemistry, The Chinese 
University of Hong Kong. The complex was solved by molecular replacement using 
the program MOLREP (Vagin & Isupov, 2001) in the CCP4 suite (Collaborative 
Computational Project, 1994). The AASA dehydrogenase (PDB: 2J6L) was used as 
the search model. The asymmetric unit contained 8 monomers of human ATQ, 
which formed two tetramers that were in agreement with known quaternary structure 
of the ALDHs. However, the electron density of a-AASA was not distinct enough, 
and only the structure of binary huATQ/NADH complex could be determined from 
the data. Models were built using REFMAC5 (Murshudov et a/.，1997). Eight-fold 
non-crystallographic symmetry restraints were applied to all atoms of residues 4-499, 
and the weighting was set to be 'tight' for main-chain and "loose" for side-chain 
atoms. Eight-fold NCS-averaged maps generated by the program COOT (Emsley 
& Cowtan，2004) was used to guide further model rebuilding. To avoid model bias, 
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model building was guided by maps generated by density-modification and 
composite-annealed-omit protocols, followed by refinement using the simulated 
annealing protocol (Brunger et <3/., 1998). Five percent of data was left out randomly 
for cross-validation, and the same data set was used by both CNS and REFMAC5 
throughout the refinement. The NADH ligand was added to the model, so its 
interaction with huATQ could be visualized for the explanation of the mutants' 
performance. 
2.2.4 Mutational Studies of Human Antiquitin 
2.2.4.1 Preparation of Mutant Plasmids 
The mutants were prepared using the QuikChange® II site-directed mutagenesis 
kit. The mutagenic primers were designed according to manufacturer's instructions 
and were listed in Table 2.1. In each reaction of mutant strand synthesis, 125 ng of 
both forward and reverse primers were added to the 50 ul mixture. Fifty ng pRSETA/ 
huATQ was used as the dsDNA template in the synthesis of all mutants. The 
extension time was 5 minutes and the reaction was run for 12 cycles. Following 1 
hour Dpnl digestion at 37°C, the product was transformed into XL-1 blue 
supercompetent cells included in the kit and spread on LB-Ampicillin (50 ug/ml) 
agar plate. DNA sequencing was performed to confirm the sequences of the mutants. 
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2.2.4.2 Expression, Purification and Kinetics Studies of mutants 
The mutants were expressed in E. coli BL21(DE3)LysS and purified as 
described for the wild-type enzyme; except that the elution buffer for huATQ-M4, 
huATQ-M6 and huATQ-M7 should be calibrated to pH 6 after the addition of 1 M 
sodium chloride and 5 mM NAD+, while that for huATQ-M2 and huATQ-M3 should 
be calibrated to pH 7.5 instead. SDS-PAGE was used to check the purity of the 
protein eluted. 
For huATQ-M2 and huATQ-M3, after eluting from the Affi-gel® blue gel, an 
additional purification step was needed. The sample was passed through a Superdex 
75 gel filtration column connected to an AKTA purifier system (Pharmacia Biotech). 
The system was equilibrated with 30 mM potassium phosphate, 1 mM EDTA, pH 6.0, 
0.2 M sodium chloride at 0.5 ml/minute. Protein sample was concentrated to 200 ul， 
and was then centrifuged at 7000 rpm, 4°C for 5 minutes to remove precipitate. 
Fractions of 0.8 ml were collected during the course of purification. The presence of 
protein was checked by Bradford assay and SDS-PAGE was run to check the purity 
of those fractions containing protein. 
The determination of kinetics properties for the mutants was done in a way 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 Results 
CHAPTER 3 
RESULTS 
3.1 Subcloning, Expression and Purification of Human Antiquitin 
In this study, the open reading frame of human ATQ encoding 511 amino 
acids was first amplified by PGR using a pair of specific primers targeting to the 
ATQ sequence in the pDNA-Dual/huATQ plasmid. Agarose gel shows the amplified 
product as a sharp band with size around 1500 basepairs (Figure 3.1 A). Amplified 
product and linearized pRSETA vector were obtained after Ndel/ EcoRI digestion 
(Figure 3.IB). 
After constructing the pRSETA/huATQ plasmid, protein expression was 
ready by simply transforming the plasmid into expression bacteria. Protein 
expression in several bacterial strains like BL21(DE3)pLysE, BL21(DE3)pLysS, 
BL21 (DE3)CodonPlus and Origami(DE3) were compared. For high target protein 
expression level and low background, BL21(DE3)pLysS was chosen. Expression 
temperature was also optimized to 3 7 � C . One mM IPTG was found to be most 
appropriate for induction, the release of the lac operon allowed the T7 promotor to drive 
protein expression. Target protein expression level in cell soluble and insoluble fractions 
at different time points was compared (Figure 3.2). The theoretical subunit molecular 
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Figure 3.2 Expression of human ATQ in BL21(DE3)pLysS cells. Bacterial culture is 
saved at various time points. SDS-PAGE analysis separates protein in the sample and 
allows comparison of target protein level in different samples. 
Lanes 1 and 2，soluble and insoluble fractions before IPTG induction; lanes 3 and 4， 
soluble and insoluble fractions 3 hours after 1 mM IPTG induction; lanes 5 and 6, 
soluble and insoluble fractions after overnight IPTG induction. Lane 7，molecular 
weight marker. 
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increased upon induction. It was also obvious that most of the over-expressed protein 
was found in the soluble fraction. 
Pure recombinant human ATQ was obtained from the cell lysate by a single 
purification step utilizing Affi-gel blue agarose. The agarose is conjugated with a 
blue dye with structure similar to NAD+. Therefore it has the capability to retain 
enzymes with a specific dinucleotide fold and is commonly used for affinifty 
chromatography. The purification process could be represented by the chromatogram 
(Figure 3.3), which clearly showed the change of aldehyde-oxidizing activity 
throughout the course. Non-specifically bound proteins in the column were removed 
by 2 successive washing steps of 1 M sodium chloride and 5 mM NAD+. The activity 
profile showed a sharp peak after the addition of elution buffer containing both 
sodium chloride and NAD+. This purification system was rather efficient since an 
increase in specific activity from 0.37 to 1.8 U/mg was recorded and the purification 
fold was 4.7 (Table 3.1). The purification yield was high as 69 %. 
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1 M NaCl buffer 5 mM NAD+ 5 mM NAD+ 
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Figure 3.3 Chromatography of bacterial cell lysate on Affi-gel Blue Agarose. 
Cell lysate from pRSETA/huATQ transformed E.coli BL21(DE3)pLysS was loaded onto 
the column (1.8 x 15 cm) equilibrated with 1 mM EDTA, 1 mM DTT, 2 mM 
benzamidine, 30 mM potassium phosphate, pH 6.0. The column was first washed with 
buffer containing 1 M sodium chloride. After washing back with one bed volume of 
equilibration buffer, buffer with 5 mM NAD+was added. Finally, ATQ was eluted with 
buffer containing 1 M sodium chloride and 5 mM NAD+. Activity was determined with 
2.5 mM NAD+，35 mM acetaldehyde in 0.1 M sodium pyrophosphate, pH 9.5. 
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Table 3.1 Purification of recombinant human ATQ from pRSETA/huATQ transformed 
BL21(DE3)pLysS cells. 
Total Total Specific Yield Purification 
protein activity'' activity (%) (Fold) 
(mg) (U) (U/mg) 
Crude extract' 15 ^ ^ - -
Affi-gel Blue LS ^ 4 J 
Agarose 
eluate 
a Supernatant obtained after centrifugation of cell lysate from 400 ml of culture medium, 
b Activity was determined using 2.5 mM NAD", 35 mM acetaldehyde in 0.1 M sodium 
pyrophosphate, pH 9.5. 
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3.2 Characterization of Human Antiquitin 
SDS-PAGE analysis revealed that the Affi-gel blue eluate was homogenous 
(Figure 3.4). A single band of molecular weight 55400 was observed. Information 
about the native molecular weight of the recombinant enzyme was obtained by size 
exclusion chromatography - multi-angle light scattering (SEC-MALS). 
Chromatogram showing a single peak confirmed that the protein sample eluted from 
Affi-gel blue agarose was pure (Figure 3.5). By combining the light scattering 
information with the concentration and refractive index data, the native molecular 
weight of human ATQ protein was found to be 208000. Since the signal was in 
coincidence with the protein peak, it was sensible to conclude that human ATQ was a 
tetramer with four similar or identical subunits. lEF revealed that the pi of human 
ATQ was 6.2 (Figure 3.6). 
The pH-rate profile of human ATQ was constructed to investigate its 
aldehyde-oxidizing performance at a range of pH (Figure 3.7). It was shown that the 
enzyme performed better in alkaline pH since a great decline in activity could be 
observed when pH went below 8. At pH 6，no activity could be observed. Enzymatic 
activity increased with pH and maximal activity was achieved at pH 8-9. 
Coenzyme is usually the leading substrate of an enzymatic reaction, and it 
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Molecular weight = 208000 / j j l 
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Figure 3.5 Size exclusion chromatography - multi-angle light scattering (SEC-MALS) 
analysis of human ATQ. 
The purified protein sample was first fractionated by a Superdex 200 column 
equilibrated with 30 mM potassium phosphate, 1 mM EDTA, pH 6.0, 0.2 M sodium 
chloride. Data from the MALS and refractive index detectors were analyzed by the 
ASTRA® 5.1.9 software. The smooth curve represents protein profile by refractive 
index data; while the bolded line segment within the protein peak corresponds to the 
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Figure 3.7 Acetaldehyde-oxidizing activity of recombinant human ATQ at different pH 
values. 
Overlapping data are measured at boundary of buffer change. Activity is indirectly 
reflected by rate o fNADH production. The activity was determined using 2.5 mM NAD+， 
14 mM acetaldehyde in 0.1 M HEPES (pH 6.0-8.0 參)，0.1 M sodium pyrophosphate 
(pH 8.0-10.0 • ) or O.IM glycine-NaOH (pH 10.0-11.0 • ) • Aldehyde-oxidizing activity 
is represented in % activity relative to the pH giving the highest activity. 
53 
Chapter 3 Results 
demonstrated to have a protective effect on ALDH at abnormal pH and high 
temperature (Fong et al, 2003). Stability studies of human ATQ also showed similar 
phenomenon. The protective effect was not obvious at pH 6-7，but significant 
difference was observed from pH 9.5 onwards (Figure 3.8). At pH 6-8, > 80 % 
activity could be kept no matter NAD+ was present or not. After 10-minute 
incubation in alkaline buffer (pH > 9.5) without NAD+, the aldehyde-oxidizing 
activity dropped to 40 % or lower. In the presence of 2 mM NAD+, 60 % activity 
could be retained. Protection by NAD+ was more prominent at high temperature 
(Figure 3.9). Activity declined to around 35 % if human ATQ was pre-incubated at 
4 0 � C for 10 minutes. However, in the presence of NAD+, full activity could be 
sustained. 
Substrate specificity study was carried out to gain information on the 
physiological substrate for human ATQ. Human ATQ was found to have a higher 
affinity on propionaldehyde than acetaldehyde (Table 3.2), showing that aldehyde 
substrate with a longer chain length was more preferable. Aromatic aldehyde like 
benzaldehyde also had a lower Km value than acetaldehyde, with the value further 
reduced by 4 fold when a negative substituent (3-nitro) was added, a- AASA had the 
lowest Km value among all the substrates tested, it was > 500 fold lower than the 
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Figure 3.8 Stability of recombinant human ATQ at different pH values. 
The enzyme was pre-incubated in buffers of different pH; 0.1 M HEPES (pH 6.0-8.0) 
(circles) or 0.1 M sodium pyrophosphate (pH 8.0-10.0) (triangles), in the absence (open 
symbols) or presence (close symbols) of 2 mM NAD+for 10 minutes. Overlapping data 
are measured at boundary of buffer change. Activity of the enzyme was determined 
using 2.5 mM NAD+，14 mM acetaldehyde in 0.1 M sodium pyrophosphate buffer, pH 
9.5. Aldehyde-oxidizing activity is represented in % activity relative to activity at pH 6 
previously incubated without NAD+. 
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Figure 3.9 Stability of recombinant human ATQ at different temperatures. 
The enzyme was incubated in 0.1 M HEPES, pH 7.5 in the presence (close symbols) or 
absence (open symbols) of 2 mM NAD% at different temperatures for 10 minutes before 
its activity was assayed with 2.5 mM NAD+，14 mM acetaldehyde in 0.1 M sodium 
pyrophosphate, pH 9.5 at room temperature. Aldehyde-oxidizing activity is represented 
in % activity relative to activity at 40°C previously incubated with NAD+. 
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Table 3.2 Kinetic parameters of recombinant human ATQ. 
Substrate Km Vmax Vmax/Km 
(mM) (U/mg) (U/mg mM) 
Acetaldehydea'c Fs O l3 
PropionaMehyde" 1.4 2.2 1.6 
B e n z a l d e h y d e ^ 0 . 8 3 0.53 0.60 
3-Nitrobenzaldehyde^'' 0.22 1.5 6.8 
a-AASAb，c 0.026 6.4 250 
NAD+b，d 0.39 - -
a Enzyme activity was determined in 0.1 M sodium pyrophosphate, pH 9.5. 
b Enzyme activity was determined in 0.1 M MOPS, pH 7.8. 
c Kinetic constants for various aldehydes were determined at 2.5 mM NAD+. 
d Km for NAD+ was determined at 0.6 mM a-AASA. 
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value for acetaldehyde. The extremely high affinity was also accompanied by a 
higher catalytic activity, which could be reflected by a high Vmax/Km value. Km for 
NAD+ was determined to be 0.39 mM. 
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3.3 Crystallization of Human Antiquitin, Diffraction Data Collection 
and Structure Determination 
3.3.1 Crystallization, Data collection and Refinement 
The initial screening of crystallization conditions for wild-type human ATQ 
with NAD+ were performed randomly using commercially available screening kits. 
Actually crystal growth was observed in a number of wells, they were either small 
granules, fine needles, regular or irregular crystals (Figure 3.10) A time of 48-96 
hours was needed for human ATQ crystal formation, as signs of crystal growth 
usually appear 2 days later and continued to transform into larger crystals in the 
following days. Potential conditions were recorded for further fine-tuning, aiming to 
produce a large, high quality crystal suitable for X-ray diffraction. Others conditions 
giving a clear drop of protein solution or protein precipitate were not favorable 
conditions for crystal growing. 
Grid screen was performed between pH 5-6 and ammonium sulfate 
concentration of 1.2-2.4 M for conditions shown in Figure 3.1 OA; while buffer of pH 
6-7 and PEG MME 550 % of 20-30% was chosen for condition B. The interval was 
narrowed to 0.1 in the final stage of the grid in order to search for the optimal 
condition. In the first attempt of X-ray diffraction, a human ATQ/NAD+ crystal 





































































































































































































































































































































































































































Chapter 3 Results 
MME 550 was diffracted to 2.6 A. It belonged to the space group P2(l). Nevertheless, 
the low completeness of the data set made refinement difficult. 
It was discovered that some outgrowth often appeared at the base of the 
crystal and might affect crystal diffraction. To strive for the formation of a more 
regular crystal, additive screens have been done. Good quality crystal was eventually 
obtained in 0.1 M BIS-TRIS, pH 6.4, 0.05 M calcium chloride dihydrate, 23% v/v 
PEG MME 550 with an additive of 0.3 M glycyl-glycyl-glycine. A second data set 
was collected from this human ATQ/NADH crystal after 2 hours soaking in mother 
liquor with 1 mM of a-AASA. This time the three-dimensional structure of human ATQ 
was also solved to 2.6 A, but with a higher % of completeness was achieved. 
Crystallographic data are summarized in Table 3.3. The crystal belonged to the space 
group C2, the monoclinic lattice had the unit cell parameters as follows: a= 265.967 A, 
b= 84.721 A, and c= 181.230 A; a = 90.0°, p = 96.97°, y= 90.0°. 
The structure was solved by molecular replacement using the AASA 
dehydrogenase (PDB: 2J6L) as the search model. Eight protein molecules were 
present in an asymmetric unit, which were actually arranged in two tetramers. However, 
the electron density of a-AASA was not distinct enough, and only the structure of 
binary huATQ/NADH complex could be determined from the data. Although the 
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Table 3.3 Crystallographic data. 
Parameter Value 
Diffraction data 
Space group C2 
Unit cell parameters a = 265.967 人，b = 84.721 人， 
c = 181.230 A; a = 90.0°, 
p = 96.97°, 7= 90.0° 
Number of molecules in an asymmetric unit 8 
Maximum resolution (A) 52.56-2.6 (2.74-2.6) 
Temperature (K) 110 
Number of measurement 687415 (75730) 
Number of unique reflection 114626 (14892) 
Redundancy 6.0 (5.1) 
Completeness (%) 93.2 (83.3) 
R m e r g e ' ( % ) 7 . 2 ( 3 8 . 0 ) 
Mean I/a(I) 22.0 (3.7) 
a 灭merge = Z M / Z ” | / ( M / ) „ " � 1轉 \ 丨 w h e r e I(hk[)n is the observed 
intensity of the «th reflection and {I{hk1)n) is the mean intensity of reflection hkl. 
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electron density of the NADH molecule was not very complete, it was still possible 
to observe one NADH molecule in each polypeptide chain. As the model was still 
under refinement, water molecules had not been added yet. Refinement statistics are 
summarized in Table 3.4. The R and Rfree factor of the latest pdb file were 22.98% 
and 28.27% respectively. Moreover, 99.8 % of the amino acids lied in the core, 
accepted and generously allowed region in the Ramachandran plot. The 8 residues that 
fell into the disallowed region corresponded to S481 in chains A-H which was found to 
locate in a tight turn in the seabream ATQ structure (Tang et al, unpublished). 
3.3.2 Human Antiquitin Structure 
Seabream and human ATQ shares 85% homology in amino acid sequence 
(Figure 3.11), thus it was not surprising that the overall structure of human ATQ 
resembled that of the seabream enzyme. The overall structure of ATQ tetramer could be 
described as a dimer of dimer (Figure 3.12). Each monomer comprised of three 
functionally distinct domains, namely the NAD+ binding domain, catalytic domain and 
oligomerization domain (Figure 3.13). 
Both the NAD+ binding and catalytic domains adopted topologically related p-a-
p type of polypeptide folding (Figure 3.14). The NAD+binding domain was formed by 
two segments of polypeptide, the N-terminal segment (residues 4-135) comprised of 4 
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Number of residues 3976 
Number of NADH molecule 8 
Mean B value (A^) 36.34 
Steroeochemistry (rmsdfrom ideality) 
Bond distance (A) 0.0083 
Bond angle (deg) 1.55 
Ramachandran plot analysis� 
Most favored regions (%) 89.7 
Allowed regions (%) 9.6 
Generously allowed regions (%) 0.5 
Disallowed regions (%) 0.2 
a i ^ w o r k = Z " F O | - | F c l l / | Z I 厂 o l ， w h c r e Fo and Fc are the observed and calculated 
amplitudes, respectively. 
b The free set contains 5739 reflections in the structure of human ATQ/NADH. 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 Results 
Figure 3.12 The ribbon diagram of human ATQ tetramer. Chains A, B, C and D are 
colored red, yellow, blue and green respectively. The figure was prepared with 
PyMOL (http://www.pvmol.org). 
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• 
Figure 3.13 Ribbon diagram of the human ATQ monomer with NADH bound. 
The three domains are highlighted in different color. The NAD+-binding domain is in 
yellow, the catalytic domain is in red and the oligomerization domain is in cyan. NADH 
is shown as a ball and stick model. The atoms are colored as follows: carbon in green; 
oxygen in red; nitrogen in blue and sulphur in orange. The figure was prepared with 
PyMOL (http://www.pvmol.org). 
67 
Chapter 3 Results 
Figure 3.14 Secondary structure of human ATQ monomer. 
a- helices, /3- sheets and loops were colored in red, yellow and green respectively. 
NADH is shown as a ball and stick model. The atoms are colored as follows: carbon in 
green; oxygen in red; nitrogen in blue and sulphur in orange. The figure was prepared 
with PyMOL (http://www.pvmol.org). 
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helices and 3 parallel sheets while the second segment (residues 157-268) comprised of 
4 a-helices and 5 parallel sheets. The catalytic domain (residues 269-455) was made up 
of 5 a-helices and 7 parallel sheets. Two anti-parallel sheets (residues 136-156, 456-499) 
constituted the oligomerization domain. 
There were 2 interfaces where monomers interact to form dimer. The first one 
involved the fifth helix (residues 248-261) in the Rossmann fold of the NAD+ binding 
domain (a8), where the helices of individual monomers contacted in an anti-parallel way. 
The second dimerization interface was found between pi6 (residues 452-455) of one 
monomer and the last p strand (317 (residues 489-497) in the oligomerization domain of 
another monomer. Tetramerization involved residues 139-142 and 436-437 of each 
monomer. The second segment of NAD+ binding domain was arranged in a 
Rossmann fold topology which was commonly found in nucleotide binding proteins. 
Similar to seabream ATQ, The human enzyme had a non-classical fold in which only 
five {(3 5-139) out of the six sheets of the fold were present and the final helix was 
missing. The adenine ring of NADH was pointing to the NAD+binding domain; while 
the nicotinamide ring was pointing to opposite direction towards the catalytic domain. 
The fourth (residues 227-235) and fifth (residues 248-261) helices of the Rossmann fold 
(a7 and a8) participated in the adenine ring binding. 
Although the human ATQ protein was co-crystallized with cofactor NADH, the 
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electron density of NADH molecules in the polypeptide chains was not complete and 
well-defined. It could be seen that the nicotinamide half of NADH did not possess any 
electron density at all (Figure 3.15). The disordered electron density actually reflected 
that this region is rather flexible. The flexibility of the nicotinamide part could also be 
confirmed by the extremely high B-factor of > 100. It is known that cofactor in ALDH 
structure can either adopt the "hydride transfer" or "hydrolysis" conformation. In human 
ATQ structure, the nicotinamide half of NADH is found to be extended, with the 
nicotinamide ring sandwiched between the side-chain of C302 and CG2 of T245 (Figure 
3.16). Thus it is believed that the NADH in current structure is adopting the "hydride 
transfer" conformation. It is because the nicotinamide ring will be sandwiched between 
the backbone of G246 and the side-chain of F401 instead in the "hydrolysis" 
conformation. In human ATQ structure, the adenine ribose oxygens of NADH are within 
hydrogen bonding distance of the side-chain nitrogen of K190. The pyrophosphate 
bridge oxygen is potentially hydrogen bonded with the backbone nitrogen of S247. The 
nicotinamide ribose oxygen N03* are within hydrogen bonding distance of the side-
chain oxygen of E399. 
The entrance of the substrate binding site was located at the opposite side of the 
NAD+ binding site (Figure 3.17). Thus the catalytic C302 was actually between the two 
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H H I H 
— 
Figure 3.15 Diagram showing the incomplete electron density of a NADH moiety in 
human ATQ. 
All atoms are colored in yellow. The figure was prepared with WinCoot. 
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Figure 3.16 Position of the NADH nicotinamide ring in human ATQ structure. 
NADH and important residues are represented in ball and stick model. All the atoms of 
NADH are colored yellow. For other residues, the atoms are colored as follows: carbon 
in green; oxygen in red; nitrogen in blue and sulphur in orange. The figure was 
prepared with PyMOL (http://www.pvmol.org). 
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Figure 3.17 Substrate binding site in human ATQ. 
The 3 helices and the surface loop constituting the pocket are colored in magenta. 
Hydrophobic residues lining the inner surface are colored in cyan. E268 involved in 
catalysis is highlighted in orange. Catalytic 302 is represented in ball and stick model 
and all the atoms are colored yellow. The 2 charged residues, E121 and R301, guarding 
the entrance of the channel are also shown in ball and stick model. They are colored as 
follows: carbon in green; oxygen in red; nitrogen in blue and sulphur in orange. The 
figure was prepared with PyMOL (http://www.pvmol.org). 
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sites, so that the cofactor and the substrate could come close for hydride transfer during 
the oxidizing reaction. Three helices and a surface loop constituted the binding pocket. 
Helices a4 and a5 (residues 112-135 and 170-183) of the NAD+binding domain made 
up the left side and back side of the tunnel; while a9 (residues 283-295) of the catalytic 
domain and a part of the loop (residues 456-465) in oligomerization domain formed the 
bottom and the right side of the opening. The inner surface of the cavity was lined with 
hydrophobic residues like N167, F168, W175,1464, F468, which are expected to form 
hydrophobic interactions with the substrate. It was found that two oppositely charged 
residues, El21 and R301 guarded the substrate entrance channel and might play 
important role in determining the substrate specificity of the enzyme. 
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3.4 Mutational Studies of Human Antiquitin 
Site-directed mutagenesis kit was utilized to generate different human ATQ 
mutants by using the existing pRSETA/wild-type huATQ plasmid as the template. 
Desired mutants could be easily obtained by introducing certain nucleotide change 
through the primer design. The human ATQ mutants were expressed and harvested 
in the same condition as the wild-type enzyme, and were also purified by Affi-gel 
blue agarose. From SDS-PAGE, it could be seen that G174V and V367G were not 
expressed in the bacterial system (Figure 3.18). All other mutants were 
overexpressed, though the target protein level of G263E was a bit lower. It was also 
found that some of the mutants, including G263E, N273I, E399Q and S430N, bound 
more tightly to the affinity column than the wild-type enzyme, since they were not 
eluted out from the column by the usual elution buffer of 1 M sodium chloride 
together with 5 mM of NAD+. Buffers with increased salt or cofactor concentration 
were employed in an attempt to elute the proteins, however, it was not successful. 
Even a combination of them made no improvement to the situation. Finally, it was 
discovered that buffer with a higher pH could elute the proteins. R307Q, E399Q and 
S430N were eluted at pH 6; while G263E and N273I could only be eluted at a much 
higher pH of 7.5 (Figure 3.19A). Nevertheless, the eluted G263E and N273I proteins 
were impure, as a major contaminant with subunit size around 27 kDa was found 
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Figure 3.19 Purification of human ATQ mutants (continued). The soluble fraction of the 
cell lysate after ultracentrifugation, the concentrated eluate from Affi-gel Blue Agarose 
and Superdex-75 are loaded to 12% polyacrylamide gel for comparison of purity. 
B. Lanes 14 and 18 are the cell lysates of G263E and N273I after overnight IPTG 
induction, lanes 15 and 19 are the corresponding semi-purified human ATQ mutants 
after Affi-gel blue agarose chromatography and lanes 16 and 20 are the purified 
mutants after Superdex 75 size-exclusion chromatography. Lane 17 is the molecular 
weight marker. 
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Superdex 75 size exclusion column. SDS-PAGE analysis showed that the final 
fractions were pure enough for subsequent kinetics study. 
Kinetic properties of the mutants towards acetaldehyde, a-AASA and NAD+ 
were determined. For G263E, N273I and E399Q, no activity could be detected under 
the conditions employed (Table 3.5). R307Q had a much lower affinity than wild-
type human ATQ towards NAD+. Therefore, 50 mM instead of 2.5 mM NAD+ was 
used to determine its Km value towards a-AASA. The Km value was 30 fold larger 
than that of the wild-type enzyme, indicating a much weaker binding affinity of the 
mutated enzyme with the substrate. The reaction also had an extremely low Vmax 
value. Similarly, S430N and A171V bound a-AASA about 20 and 10 fold weaker 
than wild-type human ATQ respectively. The Vmax value also decreased, but to a 
lesser extent than R307Q. On the other hand, the mutations in S430N and Al71V 
did not significantly alter the enzyme's affinity towards acetaldehyde. 
Mutating the charged residues along the pocket of the substrate entrance 
channel weakened the enzyme's ability to differentiate its substrate. Wild-type 
enzyme preferred a-AASA than acetaldehyde as the substrate, having a 500 fold 
lower Km value. However, this difference was reduced to only 10-20 fold after the 
mutation of the charged residue into alanine. However, no matter which substrate 



























































































































































































































































































































































































































































































































































































































































































Chapter 3 Results 
S430N, A171V and channel-related mutants El21 A, R301A all possessed a lower 
Km value towards the cofactor NAD+ than the wild-type enzyme. 
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CHAPTER 4 
DISCUSSION 
4.1 Characterization and Substrate Specificity of Recombinant 
Human Antiquitin 
In order to obtain human ATQ proteins for characterization and crystallization, 
the techniques of recombinant protein production was employed. The rationale 
behind was to engineer the target nucleotide sequence into the bacterial genome, so 
that when it was put back into the bacterial host, the desired protein can be produced 
through normal translation process. This system was proved to be successful to 
produce recombinant enzyme having amino acid sequences and enzymatic activity 
comparable to native protein (Tang et al., 2005). Actually, the Ndel site was in front 
of the multiple cloning site, so this cut allowed the removal of the sequence of the 
hexa-histidine tag originally present in the vector. The expressed protein would be 
untagged, thus no extra digestion step was required prior to enzyme characterization 
and crystallization. 
Human ATQ is found to be a homotetramer with a subunit molecular weight of 
55400 and an acidic pi of 6.2. This is consistent with most of the human ALDHs like 
ALDHlAl and ALDH2, having a tetrameric structure with subunit molecular weight 
about 55000 (Ehrig et al,, 1990; Ikawa et al., 1983) and acidic pi of 5-7 
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(Rashkovetsky et al, 1994). ALDH isozymes from human, monkey, cow, rabbit and 
rat all function best at alkaline pH (Tsutsumi et al, 1988). The optimal pH of human 
ATQ is found to be at pH 8-9 in this study. The pKa value of cysteine residue is 8.18. 
pH affects human ATQ activity because the maintenance of the catalytic C302 at a 
negative state is essential for a nucleophilic attack starting the aldehyde oxidation. 
High pH will irreversibly oxidize the cysteine and thus abolish the 
aldehyde-oxidizing activity of the enzyme. The protective effect of NAD+ on human 
ATQ at high temperature and alkaline pH agree with previous findings on seabream 
ALDH-2 and seabream ATQ (Fong et al., 2003). In earlier times, scientists have 
already noticed that addition of NAD+ or its reduced form NADH to the ALDH 
preparations preserved the enzyme activity of rat hepatic ALDH (Schreiner & 
Freundt, 1987). It is suggested that the protection against inactivation may be 
afforded by occupation of the co-substrate binding site of the enzyme. 
From the results of substrate specificity study, it is revealed that human ATQ 
prefers longer aliphatic aldehyde like propionaldehyde and aromatic aldehyde like 
benzaldehyde as its substrate when compared with the simple acetaldehyde. Thus it 
is speculated that the substrate binding site of human ATQ may somehow like a 
tunnel, accommodating medium-length aldehyde with side-chains. Their high Km 
values indicate that they are unlikely the physiological substrate of the enzyme. 
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Benzaldehyde with a nitro group as the negative substituent has a lower Km and 
higher Vmax values than its parental aldehyde. Thus the substrate binding channel of 
human ATQ probably contains a positively charged residue, so that its interaction 
with the negatively charged side-chain of the substrate favors the entry. This 
observation is also true for ALDH4, which is discovered to be a P5C-GSA 
dehydrogenase participated in proline metabolism (Forte-McRobbie & Pietruszko， 
1986). After the role of human ATQ in lysine metabolism is reported (Mills et al, 
2006), the suggested physiological substrate of the enzyme, a -AASA, is also tested 
in the present substrate specificity study. The extremely high affinity of human ATQ 
towards this substrate as reflected by the micromolar range Km value, together with 
the high catalytic efficiency verify the involvement of human ATQ in the catabolic 
pathway as P6C- a -AASA dehydrogenase. 
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4.2 Crystallization and Crystal Structure of Human Antiquitin 
4.2.1 Crystallization 
Seabream and human ATQ crystallize in similar conditions, a pH of 6.4-6.5 in 
the presence of around 20% PEG polymer. In general, human ATQ crystals have a 
higher stability than those of the seabream, 16°C instead of 4°C is employed for 
crystal growing. The seabream crystals crack easily after a week of crystal formation, 
while human ATQ crystals are stable up to months, despite some outgrowths may 
emerge at the crystal base and affect the quality of diffraction data. This phenomenon 
can be explained by the difference in physiological temperature of the 2 species. 
Human ATQ functions well in human body at 3 7 � C , while seabream lives in 
environment of around 20°C. Nevertheless, human ATQ need a longer time for 
crystal formation, usually 2-3 days; while seabream ATQ crystals appear overnight. 
4.2.2 Overall structure 
Crystal structure of human ATQ resembles those of other ALDH (Steinmetz et 
al, 1997; Moore et al., 1998)，each subunit of the tetramer is made up of 3 
discernable domains. The tetrameric structure can be described as a dimer of dimer. 
Supporting evidence is that the monomeric structure of ATQ can superimpose well 
on other ALDH monomer with a low Cot rmsd value of around 1.3 A sheep ALDHl 
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(1.23 A), Elephantulus edwardii r|-crystallin (1.34 A), bovine ALDH2 (1.26 A), rat 
ALDH3 (1.58 A), cod BALDH (1.24 A) and E. coli YdcW (1.22 A)). The mode of 
subunit organization in the dimer and dimer organization in the tetramer are said to 
be very similar to common ALDHs. 
The main difference between ATQ structure with other ALDH structures is the 
presence of a short helix a 1 (residues 13-18) at the N-terminal of the protein. This 
extended helix locates on the surface of the monomer and is not involved in catalysis 
or oligomerization. Among existing structures of ALDH, only betaine dehydrogenase 
shares this characteristic with ATQ (Johansson et al., 1998). 
Similar to seabream ATQ structure, S481 in all 8 polypeptide chains of human 
ATQ structure fell into the disallowed region in the Ramachandran plot. The residue 
is actually located on a long loop of transition from the last /3 -sheet (residues 
452-455) in the catalytic domain to a small helix (residues 484-488) in the 
oligomerization domain. Visualization through Wincoot demonstrates that the 
electron density around the residue is complete and the atoms are well enclosed by 
the density. No negative electron density is detected around the residue. It is believed 
that the complaints are not due to a wrong refinement as the observation is consistent 
with the seabream ATQ structure. Instead, such an unusual main chain conformation 
may be necessary for the residue to be positioned at the tight turn. 
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4.2.3 Cofactor binding 
The NAD+ binding domain of human ATQ displays a Rossmann fold; this 
folding is commonly found in enzymes utilizing dinucleotides as cofactor. Like other 
ALDHs, the Rossmann fold present deviates from the typical fold in several ways. 
The second polypeptide segment of the domain (residues 157-268) contains 5 /5 
-strands connected by 4 a -helices in between, which is different from the 6 
-strands arrangement usually observed in NAD^-dependent dehydrogenase structures 
(Rossmann et al., 1974). Like many other ALDH, the GXGXXG fingerprint 
sequence present on the first a - /3 loop of a typical Rossmann fold is absent in the 
human ATQ structure. On the other hand, it is replaced by a glycine-rich sequence 
GSTQVG (residues 246-251) at the / 5 D - a E loop in the fold. Because of this 
change, the original interaction between the first glycine in the fingerprint sequence 
with the pyrophosphate of the cofactor is abolished (Liu et al, 1997). 
Invariant residue E399 and highly conserved residue K190 are involved in 
NADH binding in human ATQ structure. They are hydrogen bonded with the 
nicotinamide and adenine ribose respectively. Although they are not directly 
involved in catalysis, it is believed that their role in stabilizing the position of 
cofactor for hydride transfer is indispensable, since mutation of these residues in 
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ALDH2 has made hydride transfer to become the rate-limiting step instead of 
deacylation (Corkey et al, 1986; Ni et al., 1997). 
In human ATQ structure, the electron density of the NADH molecules in all of 
the 8 chains is incomplete and poorly defined. The nicotinamide half of the NADH 
molecule in human ATQ structure is highly flexible, as reflected by the high B-factor 
of the atoms and the absence of electron density. Disordered cofactor electron 
density can also be observed in some binary ALDH structures like that of ALDH2 
(Steinmetz et a/., 1997), since NAD+ may employ 2 different conformations in these 
structures , namely the "hydride transfer" and "hydrolysis" conformations 
(Perez-Miller & Hurley, 2003). A superimposed image human mitochondrial 
aldehyde dehydrogenase complexed with NAD+ (PDB: 1004) and NADH (PDB: 1002) 
is shown in Figure 4.1. In "hydride transfer" conformation, the nicotinamide ring of 
NAD+ is extended such that it is located close to the catalytic cysteine residue. On 
the other hand, the nicotinamide ring is positioned out of the active site in the 
"hydrolysis" conformation brought about by rotations at the pyrophosphate bond 
(Perez-Miller & Hurley, 2003). As a result, the nicotinamide ring is far away from 
the catalytic cysteine residue for efficient hydride transfer. 
It is proposed that isomerization between the two conformations plays a crucial 
role in catalysis (Steinmetz et al, 1997; Moore et al., 1998). In the beginning of 
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Figure 4.1 Dual conformations ofNAD+ZNADH. 
The structure of human mitochondrial aldehyde dehydrogenase complexed with NAD+ 
(PDB: 1004) and NADH (PDB: 1002) are superimposed together. The cofactors are 
represented in ball and stick model. NAD+ shows a "hydride transfer" conformation 
(colored in yellow); while NADH shows a "hydrolysis" conformation (colored in green). 
C302 in "hydride transfer" conformation is shown as sticks; while that in "hydrolysis" 
conformation is shown as lines. The figure was prepared with PyMOL 
(http://www.pvmol.org). 
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catalysis, NAD+ is in "hydride-transfer" conformation with the C4 atom of the 
nicotinamide ring located close to the catalytic cysteine residue ready for hydride 
transfer. After the transfer of hydride to the C4 atom of NAD+, the reduced NADH 
isomerizes to the "hydrolysis" conformation where the nicotinamide ring is shifted 
towards the original position of nicotinamide ribose in the "hydride-transfer" 
conformation. Such displacement of the nicotinamide ring allows a water molecule 
to be bound and activated by the catalytic E268 for the hydrolysis of the 
thio-acylenzyme intermediate. 
4.2.4 Substrate Binding and Catalysis 
The substrate-binding pocket of human ATQ is lined with several hydrophobic 
residues like N167, F168, W175, 1464，F468, which are expected to form 
hydrophobic interactions with the substrate. Thus propionaldehyde and benzaldehyde 
are more preferable than acetaldehyde as the substrate since their aliphatic chain and 
aromatic ring can interact with the hydrophobic residues to allow entry of the 
substrate into the pocket. This is reflected as the lower Km value of human ATQ 
towards these substrates. Substrate entry is also restricted by charged residues present 
at the entrance of the channel, a pair of oppositely charges residues El21 and R301 
located 10.04 A from each other are believed to play major roles in substrate 
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Specificity. They are highly conserved among ATQ but not other members of ALDH 
superfamily (Guerrero et al, 1990; Lee et al, 1994). These unique criteria have 
made ALDH7 to be a substrate-specific family of ALDH. 
The negatively charged substituent 3-nitro group is found to reduce the Km 
value of benzaldehyde by 4 fold. This can be explained by the attraction between the 
negative nitro group of the substrate with the positive R301. Human ATQ possesses 
an extremely low Km value towards a -AASA, the suggested physiological substrate 
involved in lysine metabolic pathway. It is likely that the aliphatic chain of a 
-AASA interacts with aromatic residues lining the pocket; while its amino and 
carboxylate groups form charge-charge interactions with El21 and R301. All of the 
above interactions provide a large attractive force for a -AASA to enter and fit well 
to the substrate binding pocket. When compared with the structure of ALDH4A1 
catalyzing similar oxidation reaction of GSA to glutamate, the residues that form the 
substrate-binding pocket of the two enzymes are well conserved (Perez-Miller & 
Hurley, 2003). Actually, GSA has a similar chemical structure with a -AASA, with 
the hydrocarbon chain being shorter by one -CH2 group. The obvious difference is 
that the substrate-binding pocket of ATQ is deeper and narrower, and structural 
changes are present to provide better interaction with the longer substrate a-AASA. 
Actually, a -AASA has been modeled into the active site of seabream ATQ 
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previously (Tang et al., unpublished). The substrate fits nicely without steric clashes 
to the substrate-binding pocket. The aldehyde carbonyl is docked to the oxyanion 
hole, forming hydrogen bonds with the side chain amide of Asnl66 (corresponding 
to N167 in human ATQ) and backbone amide of Cys301 (corresponding to C302 in 
human ATQ). 
To elucidate the roles of these charged residues (El21 and R301) guarding the 
channel entrance, 2 charge-to-alanine mutants are generated. If the charged side 
chains of these residues do interact with the aldehyde substrate, alanine substitution 
on either of these residues will affect the a-AASA oxidizing activity of the mutants. 
The 2 substitutions increase the Km value of the enzyme towards a-AASA to 0.48 
and 0.88 mM; but lower the Km value of the enzyme towards acetaldehyde to 8.7 
and 8.4 mM respectively. These human ATQ mutants are said to lose the ability to 
differentiate substrates, in order words, they have declined substrate specificity. The 
2 charge-to-alanine substitutions lower the Vmax value of the enzyme towards both 
a-AASA and acetaldehyde, with the decrease in R301A mutation more prominent. 
Taken together these structural and kinetic information, El21 and R301 are 
suggested to be involved in stabilizing the enzyme-substrate complex through 
charge-charge interaction with the positively charged amino group and negatively 
charged carboxylate group of the substrate. These findings do not totally agree with 
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the previous suggestion in seabream ATQ that R300 is involved in stabilizing the 
transition state during the catalytic process but not in substrate binding since R300A 
substitution did not significantly alter the Km value (Tang et a/.,unpublished). 
The crystal structure of human ATQ provides a clearer picture to illustrate steps 
and residues involved in catalytic mechanism. The C302 and E268 which is highly 
conserved in the ALDH superfamily participate in catalysis by acting as the catalytic 
thiol and general base respectively. During aldehyde oxidation, the catalytic thiol 
C302 first makes a nucleophilic attack on the carbonyl group of the substrate 
aldehyde, forming a thiohemiacetal intermediate. The intermediate is then oxidized 
to a thioester, at the same time, the hydride is transferred to the cofactor NAD+. E268 
plays a role in the final step that it activates a water molecule for acid release and 
NADH dissociation. It is proposed that E268 is also indirectly involved in the 
formation of the hemiacetal by deprotonating C302 (Steinmetz et al, 1997). 
Similar to ALDH2 (Steinmetz et al, 1997) and seabream ATQ (Tang et al., 
unpublished), the location of E268 is remote to the catalytic components and being 
sterically blocked by the nicotinamide ring of the cofactor. It is proposed that the 
nicotinamide ring may position differently during hydride tranfer, so that E268 can 
come close for deacylation or the formation of the hemiacetal (Steinmetz et al, 
1997). 
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4.3 Mutations in Human Antiquitin Gene and their Relationship 
with Pyridoxine-dependent Seizures 
ALDH takes part in amino acid metabolism since amino acid catabolism 
generates aldehydes as intermediates. Malonate- and methylmalonate-semialdehyde 
are generated in the L-valine catabolic pathway. ALDH6A1 catalyzes their oxidative 
decarboxylation to acetyl- and propionyl-CoA respectively (Vasiliou & Pappa，2000). 
ALDH6A1 deficiency is an inborn metabolic disorder that results in developmental 
delay (Roe et al, 1998). 
GSA is generated during the metabolism of proline and arginine. This 
semialdehyde, in nonenzymatic equilibrium with P5C, is oxidized by the 
mitochondrial ALDH4A1 to glutamate (Vasiliou et al., 2004). Loss of ALDH4A1 
function causes type II hyperprolinemia, an autosomal recessive disorder 
characterized by plasma accumulation of proline and P5C, and neurological 
manifestations such as seizures and mental retardation (Valle et al., 1976). A 
possible interaction between P5C and PLP (vitamin B6 coenzyme) has been reported, 
which implicates the former as an endogenous vitamin antagonist and vitamin B6 
deactivation may contribute to seizures in type II hyperprolinemia (Farrant et al., 
2001). 
ATQ is found to perform similar function in the lysine catabolic pathway, 
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catalyzing the oxidation of a -AASA to a-AAA (Mills et al., 2006). Defective ATQ 
function will result in PDS characterizaed by elevated urinary a -AASA level and 
recurrent long-lasting seizures (Bok et al., 2007). P6C, the equilibrium product of a 
-AASA, deactivates pyridoxal phosphate in a similar way as P5C and finally leads to 
seizures. Indeed, ALDH4A1 and ALDH7A1 do share a common insertion at residues 
435-436 corresponding to the catalytic domain of ATQ and are evolutionary close to 
each other as shown by phylogenetic analysis (Perozich et a/.，1999). 
To investigate the consequences of certain point mutations in human ATQ gene 
on the enzyme's activity, a series of 8 pathological mutants, as identified in Plecko et 
al. (2006)，are generated by site-directed mutagenesis. Their positions in the human 
ATQ are shown in Figure 4.2. Amino acid sequence alignment revealed that E399 is 
an invariant residue among ALDH families (Perozich et al, 1999). Although A171, 
G174, G263, N273, R307 and S430 are not conserved for ALDHs, it is conserved 
among ATQ (Tang et al, 2005). The remaining V367 is found to be replaced by 
isoleucine in some species (Plecko et al, 2006). 
Despite getting across sequence confirmation and antibiotics selection, G174V 
and V367G are not expressed from the IPTG-induced bacterial culture. Protein fails 
to express in E.coli may be of different reasons, for example, plasmid instability. 
Plasmid instability is categorized as segregational instability and structural 
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Figure 4.2 PDS-related mutations in human ATQ. 
The NAD+-binding domain, catalytic domain and oligomerization domain are colored in 
yellow, red and cyan respectively. 
Mutated residues are represented in ball and stick model. The atoms are colored as 
follows: carbon in green; oxygen in red; nitrogen in blue and sulphur in orange. The 
figure was prepared with PyMOL (http://www.pvmol.org). 
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Stability. Segregational instability is the loss of plasmid from one of the daughter 
cells during division because of defective partitioning. Structural instability is 
attributed to deletions, insertions and rearrangements in the plasmid structure, 
resulting in the loss of the desired gene function (Rai & Padh, 2001). Plasmid 
stability is influenced by the vector and host genotypes, that is, the same plasmid in 
different hosts exhibits different degrees of stability. The origin and size of foreign 
DNA have also been observed to affect plasmid stability. Protein stability is unlikely 
the explanation here because no extra bands of smaller size can be observed in the 
SDS-PAGE analyses of these mutants, i.e. sign of protein degradation is absent. 
Protein toxicity is also believed to be not the reason, since the transformants of the 
mutant plasmids grow at a similar rate during culture. Thus the first thing to be done 
is to check for the integrity of the clone taken for protein overexpression. Secondly, a 
different strain of BL21(DE3) CodonPlus can be tried for protein expression. Codon 
usage is a problem which usually found to obstruct efficient heterologous protein 
expression, since forced high-level expression of heterologous proteins can deplete 
the pool of rare tRNAs and stall translation. This bacteria strain contains extra copies 
of genes encoding the tRNAs that most frequently limit translation of heterologous 
proteins in E. coli and allows high-level expression of many heterologous 
recombinant genes. 
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Although recombinant protein of these mutants cannot be obtained, it is possible 
to understand better the role of these residues by viewing at the 3-dimensional 
structure of human ATQ. G174 locates on a 5 which constitutes part of the substrate 
binding site. The substitution of glycine with valine containing 2 extra methyl groups 
will lead to steric clashes with surrounding bulky residues on helix a 4 such as Y122 
and 1125. On the other hand, V367 locates on 12 which is on the surface of the 
monomer. The role of this variable residue is not well understood, but seems that it is 
not involved in cofactor binding, substrate binding nor oligomerization. 
E399Q and A171V are the 2 point mutations being earliest reported as their 
mutations are in association with PDS. Transfection of CHO cells with ALDH7A1 
encoding E399Q and A171V produced undetectable a -AASA dehydrogenase 
activity (Mills et al., 2006). PDS patients having the mutation of E399Q in both 
alleles have an extremely high a -AASA concentration in urine and plasma, as well 
as a high plasma concentration of pipecolic acid (PA) which is the precursor of a 
-AASA in the pathway (Plecko et al, 2006). E399Q is a common mutation in PDS 
patients. In the recent study of Plecko et al. (2006), it is identified in 12 out of 36 
alleles in a cohort of 18 patients. The effect of E399Q point mutation is the most 
disastrous among all. This, together with the invariant property of this residue, 
reflects its importance in ALDH catalysis. 
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The E399Q mutant generated in this study fails to display any 
aldehyde-oxidizing activity towards both a -AASA and acetaldehyde. Actually, the 
effect of a glutamine substitution at this position has been previously demonstrated in 
human ALDH2 (Ni et al., 1997). From the human ATQ structure, it can be seen that 
E399 is close to the nicotinamide ribose ofNADH. A change of this acidic residue to 
a neutral glutamine will disturb the original interaction with the cofactor and result in 
a decrease in enzyme activity. 
On the other hand, A171V poses a milder effect on human ATQ activity. When 
compared with the wild-type enzyme, this substitution increases the Km value by 10 
fold and decreases the Vmax value by 6 fold. Interestingly, the kinetics of the mutant 
enzyme towards acetaldehyde is not significantly altered. A171 is positioned just 
below G174 on helix a 5, forming part of the substrate binding pocket. Similarly, 
the alanine-to-valine substitution will cause steric clashes between the valine 
side-chain and the surrounding residues in the substrate-binding pocket like E121, 
F168 and W175. It is believed that the protrusion of the extra methyl group into the 
binding pocket will somehow obstruct the original good-fit position of a-AASA, 
resulting in decreased affinity. However, the small size of acetaldehyde enables it to 
enter the pocket without hinderance. In addition, A171 is probably involved in the 
stabilization of the transition state during the catalytic process since the Vmax values 
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decrease in both cases. 
G263E and N273I missense mutations on human ATQ gene have been identified 
by molecular analysis within the cohort of 18 patients (Plecko et al, 2006). They are 
not prevalent mutations since each of them only account for 1 of the 36 alleles within 
the cohort. Nevertheless, human ATQ activity is significantly impaired by these 
mutations, as shown by the elevated level of plasma PA, plasma a -AASA and 
urinary a -AASA in patients carrying these mutations. Our recombinant mutants also 
agree with this, as no detectable enzymatic activity can be observed towards a 
-AASA and acetaldehyde. G263 locates on the last a 13 turn in the Rossmann fold, 
between a 8 and /39. Substitution of this small glycine with the negatively charged 
glutamate bearing a long side-chain will lead to clashes with nearby bulky residues 
like N240 and L241 on /38. The Rossmann fold is thus largely disrupted, affecting 
the enzyme's ability to bind NAD+. Referring to the purification process of the 
G263E mutant, the binding between its NAD+binding domain with the dinucleotide 
analogue, Cibacron Blue F3GA dye immobilized on Affi-gel blue agarose seems to 
be stronger, as the pH of the elution buffer have to be increased to 7.5 for protein 
elution. It is postulated that after water activation and acid release, tighter binding of 
the cofactor makes NADH dissociation difficult, resulting in a dead-end 
enzyme-cofactor complex which prevents further catalysis. On the other hand, N273 
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locates on the loop linking the last /3 -sheet 冷 9 in the Rossmann fold to the first /5 
-sheet 10 of the catalytic domain. The residue is originally in close proximity with 
2 neighboring threonine residues, T303 (3.07 A) and T459 (4.12 A). If the original 
asparagine is mutated to a bulkier, nonpolar isoleucine, clashes will arise between its 
side-chains with the 2 threonine residues. These 2 threonine residues actually line in 
the inner surface of the substrate binding pocket, with T303 even next to the catalytic 
C302. Such collision may block the substrate access to the catalytic thiol, such that 
the thiol is unable to make a nucleophilic attack on the carbonyl group of the 
substrate aldehyde. As a result, catalysis cannot start and the enzymatic activity of 
the N273I mutant is completely abolished. 
PDS patients are also identified as having alterations in codon 307 (Plecko et al., 
2006). They either suffer a R307Q or R307X nonsense mutation, the latter will lead 
to the production of a truncated enzyme lacking the C-terminal. Kinetic study of the 
R307Q mutant revealed that a 20 fold higher concentration of NAD+, that is, 50 mM, 
is required to drive the oxidation of a -AASA. The Km and Vmax value are 
significantly increased and decreased respectively. The affinity of this mutant 
towards NAD+ is found to be reduced by more than 80 fold when compared with the 
wild-type enzyme. R307 is found on a small /3- sheet yS 11 of the catalytic domain. 
Originally, the long hydrocarbon chain of arginine allows it to avoid collision with 
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the aromatic ring of the nearby F309. However, substitution of arginine with a 
shorter glutamine makes things worse. Also the side chain nitrogen of the original 
basic arginine forms several hydrogen bonds with surrounding residues like N272 
and N420, such interactions will be absent when arginine is replaced by glutamine. 
The position of R307 shows that it may not be directly involved in cofactor or 
substrate binding. Thus, the mechanism of how the R307Q mutation leads to lower 
affinity towards NAD+ and a -AASA remains to be elucidated. 
S430N is found to increase the Km value towards a -AASA by 10 fold; while 
the Km value towards acetaldehyde is not significantly affected. S430 is present on 
15 in the catalytic domain. Substitution with a longer asparagine will lead to 
clashes with the surrounding bulky residues F432 and 1457. 1457 locates on the loop 
forming the right part of the substrate binding domain. Perturbation of this residue is 
believed to affect the position of the loop, which in turn affects the entry of larger 
size substrates. Furthermore, substitution of S430 leads to a decrease in Vmax value, 
reflecting its role in stabilizing the transition state during the catalytic process. 
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4.4 Comparison of Antiquitin and Other Aldehyde Dehydrogenases 
ATQ shares low amino acid sequence homology with other members in the 
ALDH superfamily. However, its physical properties are similar to most of the 
ALDHs. The protein is a homotetramer, having a pi near to neutral. ATQ possesses 
narrow substrate specificity, which is a characteristic of the "Class 3" trunk ALDH. 
ATQ is involved in the oxidation of a -AASA generated in lysine catabolism, the 
role of detoxification by aldehyde oxidation is a common feature among ALDH 
families. ATQ also follows the common 2-steps catalytic mechanism previously 
reported for other ALDHs. Nevertheless, the ability of ATQ to oxidize aldehydes 
contributes to diversified functions in different living systems. In plants, ATQ is 
widely reported to take part in osmoregulation; while in humans, it is involved 
indirectly in neurological functions. Moreover, preliminary data even suggested that 
ATQ may also play a role in cell growth and development, as overexpressing human 
ATQ in cell lines always lead to cell death. 
Structurally, ATQ also resembles most of the ALDHs with known structures. 
The tetrameric arrangement is actually a dimer of dimer. Each monomer is further 
divided into different domains for discrete functions. The cofactor-binding domain 
contains an atypical Rossmann fold and most of the highly conserved residues like 
E399 and K190. The nicotinamide half of the NADH moiety in human ATQ is found 
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to be highly flexible, supporting the suggestion that cofactor isomerization is 
essential for aldehyde oxidation reaction. On the contrary, residues located in the 
substrate binding pocket are rather variable. This provides the basis of substrate 
specificity of certain classes of ALDHs. The long entrance channel in ATQ can also 
be found in ALDH4A1 that oxidizes glutamate semialdehyde, which this may be a 
criteria to accommodate the long aliphatic chain of the substrate. 
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Stability. Segregational instability is the loss of plasmid from one of the daughter 
cells during division because of defective partitioning. Structural instability is 
attributed to deletions, insertions and rearrangements in the plasmid structure, 
resulting in the loss of the desired gene function (Rai & Padh, 2001). Plasmid 
stability is influenced by the vector and host genotypes, that is, the same plasmid in 
different hosts exhibits different degrees of stability. The origin and size of foreign 
DNA have also been observed to affect plasmid stability. Protein stability is unlikely 
the explanation here because no extra bands of smaller size can be observed in the 
SDS-PAGE analyses of these mutants, i.e. sign of protein degradation is absent. 
Protein toxicity is also believed to be not the reason, since the transformants of the 
mutant plasmids grow at a similar rate during culture. Thus the first thing to be done 
is to check for the integrity of the clone taken for protein overexpression. Secondly, a 
different strain of BL21(DE3) CodonPlus can be tried for protein expression. Codon 
usage is a problem which usually found to obstruct efficient heterologous protein 
expression, since forced high-level expression of heterologous proteins can deplete 
the pool of rare tRNAs and stall translation. This bacteria strain contains extra copies 
of genes encoding the tRNAs that most frequently limit translation of heterologous 
proteins in E. coli and allows high-level expression of many heterologous 
recombinant genes. 
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Although recombinant protein of these mutants cannot be obtained, it is possible 
to understand better the role of these residues by viewing at the 3-dimensional 
structure of human ATQ. G174 locates on a 5 which constitutes part of the substrate 
binding site. The substitution of glycine with valine containing 2 extra methyl groups 
will lead to steric clashes with surrounding bulky residues on helix a 4 such as Y122 
and 1125. On the other hand, V367 locates on j3 12 which is on the surface of the 
monomer. The role of this variable residue is not well understood, but seems that it is 
not involved in cofactor binding, substrate binding nor oligomerization. 
E399Q and A171V are the 2 point mutations being earliest reported as their 
mutations are in association with PDS. Transfection of CHO cells with ALDH7A1 
encoding E399Q and A171V produced undetectable a -AASA dehydrogenase 
activity (Mills et al., 2006). PDS patients having the mutation of E399Q in both 
alleles have an extremely high a -AASA concentration in urine and plasma, as well 
as a high plasma concentration of pipecolic acid (PA) which is the precursor of a 
-AASA in the pathway (Plecko et al, 2006). E399Q is a common mutation in PDS 
patients. In the recent study of Plecko et al (2006), it is identified in 12 out of 36 
alleles in a cohort of 18 patients. The effect of E399Q point mutation is the most 
disastrous among all. This, together with the invariant property of this residue, 
reflects its importance in ALDH catalysis. 
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The E399Q mutant generated in this study fails to display any 
aldehyde-oxidizing activity towards both a -AASA and acetaldehyde. Actually, the 
effect of a glutamine substitution at this position has been previously demonstrated in 
human ALDH2 (Ni et al, 1997). From the human ATQ structure, it can be seen that 
E399 is close to the nicotinamide ribose of NADH. A change of this acidic residue to 
a neutral glutamine will disturb the original interaction with the cofactor and result in 
a decrease in enzyme activity. 
On the other hand, A171V poses a milder effect on human ATQ activity. When 
compared with the wild-type enzyme, this substitution increases the Km value by 10 
fold and decreases the Vmax value by 6 fold. Interestingly, the kinetics of the mutant 
enzyme towards acetaldehyde is not significantly altered. A171 is positioned just 
below G174 on helix a 5, forming part of the substrate binding pocket. Similarly, 
the alanine-to-valine substitution will cause steric clashes between the valine 
side-chain and the surrounding residues in the substrate-binding pocket like E121, 
F168 and W175. It is believed that the protrusion of the extra methyl group into the 
binding pocket will somehow obstruct the original good-fit position of a-AASA, 
resulting in decreased affinity. However, the small size of acetaldehyde enables it to 
enter the pocket without hinderance. In addition, A171 is probably involved in the 
stabilization of the transition state during the catalytic process since the Vmax values 
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decrease in both cases. 
G263E and N273I missense mutations on human ATQ gene have been identified 
by molecular analysis within the cohort of 18 patients (Plecko et al., 2006). They are 
not prevalent mutations since each of them only account for 1 of the 36 alleles within 
the cohort. Nevertheless, human ATQ activity is significantly impaired by these 
mutations, as shown by the elevated level of plasma PA, plasma a -AASA and 
urinary a -AASA in patients carrying these mutations. Our recombinant mutants also 
agree with this, as no detectable enzymatic activity can be observed towards a 
-AASA and acetaldehyde. G263 locates on the last a (3 turn in the Rossmann fold, 
between a 8 and /3 9. Substitution of this small glycine with the negatively charged 
glutamate bearing a long side-chain will lead to clashes with nearby bulky residues 
like N240 and L241 on /38. The Rossmann fold is thus largely disrupted, affecting 
the enzyme's ability to bind NAD+. Referring to the purification process of the 
G263E mutant, the binding between its NAD+binding domain with the dinucleotide 
analogue, Cibacron Blue F3GA dye immobilized on Affi-gel blue agarose seems to 
be stronger, as the pH of the elution buffer have to be increased to 7.5 for protein 
elution. It is postulated that after water activation and acid release, tighter binding of 
the cofactor makes NADH dissociation difficult, resulting in a dead-end 
enzyme-cofactor complex which prevents further catalysis. On the other hand, N273 
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locates on the loop linking the last /S -sheet /39in the Rossmann fold to the first /3 
-sheet 13 10 of the catalytic domain. The residue is originally in close proximity with 
2 neighboring threonine residues, T303 (3.07 A) and T459 (4.12 A). If the original 
asparagine is mutated to a bulkier, nonpolar isoleucine, clashes will arise between its 
side-chains with the 2 threonine residues. These 2 threonine residues actually line in 
the inner surface of the substrate binding pocket, with T303 even next to the catalytic 
C302. Such collision may block the substrate access to the catalytic thiol, such that 
the thiol is unable to make a nucleophilic attack on the carbonyl group of the 
substrate aldehyde. As a result, catalysis cannot start and the enzymatic activity of 
the N273I mutant is completely abolished. 
PDS patients are also identified as having alterations in codon 307 (Plecko et ah, 
2006). They either suffer a R307Q or R307X nonsense mutation, the latter will lead 
to the production of a truncated enzyme lacking the C-terminal. Kinetic study of the 
R307Q mutant revealed that a 20 fold higher concentration of NAD+, that is, 50 mM, 
is required to drive the oxidation of a -AASA. The Km and Vmax value are 
significantly increased and decreased respectively. The affinity of this mutant 
towards NAD+ is found to be reduced by more than 80 fold when compared with the 
wild-type enzyme. R307 is found on a small /5 - sheet /311 of the catalytic domain. 
Originally, the long hydrocarbon chain of arginine allows it to avoid collision with 
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the aromatic ring of the nearby F309. However, substitution of arginine with a 
shorter glutamine makes things worse. Also the side chain nitrogen of the original 
basic arginine forms several hydrogen bonds with surrounding residues like N272 
and N420, such interactions will be absent when arginine is replaced by glutamine. 
The position of R307 shows that it may not be directly involved in cofactor or 
substrate binding. Thus, the mechanism of how the R307Q mutation leads to lower 
affinity towards NAD+ and a-AASA remains to be elucidated. 
S430N is found to increase the Km value towards a -AASA by 10 fold; while 
the Km value towards acetaldehyde is not significantly affected. S430 is present on 
15 in the catalytic domain. Substitution with a longer asparagine will lead to 
clashes with the surrounding bulky residues F432 and 1457. 1457 locates on the loop 
forming the right part of the substrate binding domain. Perturbation of this residue is 
believed to affect the position of the loop, which in turn affects the entry of larger 
size substrates. Furthermore, substitution of S430 leads to a decrease in Vmax value, 
reflecting its role in stabilizing the transition state during the catalytic process. 
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4.4 Comparison of Antiquitin and Other Aldehyde Dehydrogenases 
ATQ shares low amino acid sequence homology with other members in the 
ALDH superfamily. However, its physical properties are similar to most of the 
ALDHs. The protein is a homotetramer, having a pi near to neutral. ATQ possesses 
narrow substrate specificity, which is a characteristic of the "Class 3" trunk ALDH. 
ATQ is involved in the oxidation of a -AASA generated in lysine catabolism, the 
role of detoxification by aldehyde oxidation is a common feature among ALDH 
families. ATQ also follows the common 2-steps catalytic mechanism previously 
reported for other ALDHs. Nevertheless, the ability of ATQ to oxidize aldehydes 
contributes to diversified functions in different living systems. In plants, ATQ is 
widely reported to take part in osmoregulation; while in humans, it is involved 
indirectly in neurological functions. Moreover, preliminary data even suggested that 
ATQ may also play a role in cell growth and development, as overexpressing human 
ATQ in cell lines always lead to cell death. 
Structurally, ATQ also resembles most of the ALDHs with known structures. 
The tetrameric arrangement is actually a dimer of dimer. Each monomer is further 
divided into different domains for discrete functions. The cofactor-binding domain 
contains an atypical Rossmann fold and most of the highly conserved residues like 
E399 and K190. The nicotinamide half of the NADH moiety in human ATQ is found 
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to be highly flexible, supporting the suggestion that cofactor isomerization is 
essential for aldehyde oxidation reaction. On the contrary, residues located in the 
substrate binding pocket are rather variable. This provides the basis of substrate 
specificity of certain classes of ALDHs. The long entrance channel in ATQ can also 
be found in ALDH4A1 that oxidizes glutamate semialdehyde, which this may be a 
criteria to accommodate the long aliphatic chain of the substrate. 
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CHAPTER 5 
FUTURE PROSPECTS 
In the present study, only the binary structure of human ATQ/NADH was solved 
to 2.6 A. Despite soaking of the co-crystal in the physiological substrate a -AASA 
for 2 hours, entry of the substrate into the crystal lattice seems not satisfactory. The 
electron density is so diffuse that it is difficult to determine whether a water molecule, 
ring form P6C molecule or aliphatic a -AASA is present in the substrate binding site. 
Thus the original plan of determining the ternary structure is not successful. 
Furthermore, at such a low resolution, electron density of the residues' side chains is 
always missing. Though, the binary structure is used in this thesis to explain the 
effect of certain point mutations on the catalytic reaction. It is still worthy to 
determine the ternary structure in the future. Since upon substrate binding, the 
enzyme may undergo some conformational change to facilitate catalysis and the 
ternary structure will provide the clearest picture of their mode of interaction during 
the reaction. To solve the substrate entry problem, one way is to prepare a ternary 
crystal with NADH and a -AASA co-crystallize with human ATQ. Another 
objective is to reach a better resolution so as to facilitate subsequent refinement 
process. During the last data collection process, addition of 1,6-hexandiol is found to 
alter the way of packing of protein molecules in the crystal, resulting in a totally 
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different space group. The smaller unit cell will enable a data set of higher resolution 
to be collected. 
Upon the discovery of the linkage between human ATQ's enzymatic activity and 
PDS, the detoxifying role of ATQ in amino acid metabolism is interpreted. The most 
direct benefit to human beings is probably the use of elevated a -AASA level as a 
biomarker for PDS diagnosis (Struys & Jakobs, 2007) and mutations in ALDH7A1 
gene as the disease genotype of PDS in genetic screening. 
Nevertheless, ALDH are multifunctional enzymes that play roles besides 
detoxification. One example is the proliferation-suppressive function of ALDH3A1 
(Pappa et al., 2005). Through the modulation of several cell cycle-related proteins, 
DNA synthesis of the ALDH3 A1 -overexpressing cells is reduced and its cell cycle is 
elongated. Together with its detoxifying function, ALDH3A1 effectively protects 
corneal epithelial cells from oxidative damage. This enzyme demonstrated high 
substrate specificity for a series of medium-chain saturated and unsaturated 
aldehydes, including 4-hydroxy-2-nonenal generated by the peroxidation of cellular 
lipids. However, it is unclear whether or not the growth inhibitory effect is the effect 
of increased ALDH3A1 activity and the subsequent variations in substrate or product 
concentrations have not been determined. 
For academic interest, it is worthy to find out whether ALDH7A1 exerts similar 
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growth inhibitory effect as ALDH3A1 on human cells. Normal human embryonic 
kideney cell line HEK293 stably transfected with human ATQ has been constructed 
(data not shown). A significant reduction in cell growth and even cell death has been 
observed when compared with mock-transfected cells. It is suspected that this 
observation is due to the accumulation of a -AAA, which is the specific catalytic 
product of ALDH7A1, in the cells as a result of the increased enzyme concentration. 
a -AAA, is a glutamate analogue and gliotoxin that is known to cause injury of 
retinal Muller glial cells (Ishikawa & Mine, 1983). a - A A A could cause a rapid 
increase of intracellular calcium ion concentration (Wakakura & Yamamoto，1992) 
and block cysteine/glutamate antiporter (Kato et al, 1993) as well as Na+-dependent 
glutamate uptake (Pannicke et aL, 1994). These may account for the known potent 
gliotoxicity of a -AAA. Intravitreal injection of a -AAA is found to lead to a 
delayed expression of beta-amyloid precursor protein and B cell lymphoma 
oncogene protein in developing Muller glial cells (Chen et al, 1999). Thus, the 
metabolic integrity of Muller cells was temporarily compromised. This may have 
adverse effects on the developing neurons that are vulnerable or dependent on trophic 
support from the Muller glial cells. 
It is found that the growth inhibition effect brought about by ALDH7A1 
overexpression is so severe that the cells cannot grow to a certain passage for assay. 
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To further investigate the mechanism involved in cell death by ALDH7A1 
overexpression, it is essential to develop a system to avoid cell death. Tet-on system 
(Gossen & Bujard, 1992; Baron & Bujard, 2000) may be a good alternative. Target 
gene expression is dependent on the activity of an inducible transcriptional activator; 
while the expression of the transcriptional activator can be regulated both reversibly 
and quantitatively by exposing the eukaryotic cells to varying concentrations of 
tetracycline, or derivatives such as doxycycline. On the contrary, siRNA can also be 
used to knockdown the human ATQ gene, so that its effect on cell growth can be 
observed from another side. Antisense technology has been used previously to study 
the effect of ALDH3 (Muzio et al, 2003). 
A glial cell line should be used to best mimic the physiological environment 
where ATQ functions. By counting cell number and following rate of 
bromodeoxyuridine (BrdU) incorporation, the effect of human ATQ on cell growth 
and DNA synthesis can be confirmed and quantified. To differentiate whether these 
effects depend on ATQ's catalytic activity, a C302-mutated gene of human ATQ can 
be transfected into the cells. For deeper understanding of the molecular mechanisms 
involved, flow cytometry and Western blot can be employed to check for cell cycle 
arrest. Assays to detect apoptosis and cell differentiation can also be conducted upon 
different findings. It is hoped that, with the results of structural and functional studies, 
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the physiological roles of human ATQ can be understood more comprehensively, and 
eventually PDS patients may benefit from this. 
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